Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20050038419 A9
Publication typeApplication
Application numberUS 10/357,156
Publication dateFeb 17, 2005
Filing dateFeb 3, 2003
Priority dateSep 9, 1994
Also published asCA2515029A1, EP1592358A2, US8025661, US8241272, US8277444, US8366705, US8444639, US20040006333, US20060253113, US20070078451, US20090221997, US20120116353, WO2004069072A2, WO2004069072A3
Publication number10357156, 357156, US 2005/0038419 A9, US 2005/038419 A9, US 20050038419 A9, US 20050038419A9, US 2005038419 A9, US 2005038419A9, US-A9-20050038419, US-A9-2005038419, US2005/0038419A9, US2005/038419A9, US20050038419 A9, US20050038419A9, US2005038419 A9, US2005038419A9
InventorsJeffrey Arnold, Edward Sinofsky, Lincoln Baxter, Norman Farr
Original AssigneeCardiofocus, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Coaxial catheter instruments for ablation with radiant energy
US 20050038419 A9
Abstract
Ablation methods and instruments are disclosed for creating lesions in tissue, especially cardiac tissue for treatment of arrhythmias and the like. Percutaneous ablation instruments in the form of coaxial catheter bodies are disclosed having at least one central lumen therein and having one or more balloon structures at the distal end region of the instrument. The instruments include an energy emitting element which is independently positionable within the lumen of the instrument and adapted to project radiant energy through a transmissive region of a projection balloon to a target tissue site. The instrument can optionally include at least one expandable anchor balloon disposed about, or incorporated into an inner catheter body designed to be slid over a guidewire. This anchor balloon can serve to position the device within a lumen, such as a pulmonary vein. A projection balloon structure is also disclosed that can be slid over the first (anchor balloon) catheter body and inflated within the heart, to define a staging from which to project radiant energy. An ablative fluid can also be employed outside of the instrument (e.g., between the balloon and the target region) to ensure efficient transmission of the radiant energy when the instrument is deployed. In another aspect of the invention, generally applicable to a wide range of cardiac ablation instruments, mechanisms are disclosed for determining whether the instrument has been properly seated within the heart, e.g., whether the device is in contact with a pulmonary vein and/or the atrial surface, in order to form a lesion by heating, cooling or projecting energy. This contact-sensing feature can be implemented by an illumination source situated within the instrument and an optical detector that monitors the level of reflected light. Measurements of the reflected light (or wavelengths of the reflected light) can thus be used to determine whether contact has been achieved and whether such contact is continuous over a desired ablation path.
Images(15)
Previous page
Next page
Claims(78)
1. A cardiac ablation instrument comprising:
a catheter body adapted for disposition within a heart having at least one lumen therein, which body can be deployed at a desired location within the heart; and
an energy emitter movable within a lumen of the catheter body such that it can be disposed at the desired location and deliver ablative energy to a target tissue site.
2. The instrument of claim 1, wherein the energy emitter is slidably disposed within a lumen of the catheter body and the instrument further comprises a translatory mechanism for positioning the emitter at a selected location within the catheter body.
3. The instrument of claim 1, wherein the energy emitter is a radiant energy emitter.
4. The instrument of claim 1, wherein the energy emitter projects a ring of radiant ablative energy of variable diameter based on its axial position within the catheter body.
5. The instrument of claim 3 wherein the catheter body further comprises a projection balloon.
6. The instrument of claim 5 wherein the catheter body further comprises a projection balloon adapted for inflation in proximity to a pulmonary vein ostium to provide a transmission pathway for radiant energy.
7. The instrument of claim 3, wherein the radiant energy emitter further comprises a light transmitting optical fiber adapted to receive radiant energy from a light source and a light emitting tip at a distal end of the fiber for emitting light.
8. The instrument of claim 7, wherein the light emitting tip further comprises a beam forming optical waveguide for projecting an annular beam of light, such that the radiant energy emitter projects a ring of ablative energy of variable diameter based on its axial position within the catheter body.
9. The instrument of claim 3 wherein the instrument further comprises a light source for generating photoablative radiation at desired wavelengths ranging from between about 800 nm and about 1000 nm.
10. The instrument of claim 3, wherein the instrument further comprises a light source for generating photoablative radiation at a desired wavelength ranging from about 915 nm to about 980 nm.
11. The instrument of claim 3, wherein the energy emitter comprises an ultrasound generator.
12. The instrument of claim 11, wherein the ultrasound generator generates ultrasound energy at at least one wavelength in the range of about 5 to about 20 MHz.
13. The instrument of claim 11, wherein the ultrasound generator generates ultrasound energy at at least one wavelength in the range of about 7 to about 10 MHz.
14. The instrument of claim 3, wherein the energy emitter comprises a microwave generator.
15. The instrument of claim 5, wherein the instrument further comprises a contact sensor for sensing contact between the projection balloon and target tissue.
16. The instrument of claim 15, wherein the contact sensor further comprises a contact sensing element movable within a lumen of the catheter body such that it can be disposed at various locations to detect reflected radiant energy and, based on the reflected energy, select a desired location for forming a lesion.
17. The instrument of claim 15, wherein the reflectance sensor further comprises a light detector for detecting reflected light energy.
18. The instrument of claim 15, wherein the reflectance sensor further comprises an ultrasound detector for detecting reflected ultrasound energy.
19. A cardiac ablation instrument comprising:
a catheter body adapted for disposition within a heart having at least one lumen therein; and
a contact sensing element movable within a lumen of the catheter body such that it can be disposed at various locations to detect reflected radiant energy and, based on the reflected energy, select a desired location for forming a lesion.
20. The instrument of claim 19, wherein the contact sensing element further comprises a light detector for detecting reflected light energy.
21. The instrument of claim 19, wherein the contact sensing element further comprises an ultrasound detector for detecting reflected ultrasound energy.
22. The instrument of claim 19 wherein the instrument further comprises a projection balloon for clearing a transmission pathway for radiant energy from an energy emitter to a target treatment site.
23. The instrument of claim 19 wherein the instrument further comprises at least one optical sensor within the instrument for receiving reflected light.
24. The instrument of claim 23 wherein the instrument further comprises a source of illumination for illuminating a region surrounding the instrument and inducing reflected light that can be collected by the optical sensor.
25. The instrument of claim 23 wherein the instrument further comprises a detector capable of distinguishing at least two wavelengths of reflected light.
26. The instrument of claim 19, wherein the instrument further comprises a radiant energy emitter that is slidably disposed within a lumen of the catheter body and the instrument further comprises a translatory mechanism for positioning the emitter at a selected location within the catheter body.
27. The instrument of claim 26, wherein the radiant energy emitter further comprises a light transmitting optical fiber adapted to receive radiant energy from a light source and beam forming optics at a distal end of the fiber for projecting an annular beam of light.
28. The instrument of claim 27, wherein the instrument further comprises a light source for generating photoablative radiation at desired wavelengths ranging from between about 800 nm and about 1000 nm
29. The instrument of claim 26, wherein the radiant energy emitter comprises an ultrasound generator.
30. The instrument of claim 26, wherein the radiant energy emitter comprises a microwave generator.
31. The instrument of claim 19 wherein the instrument further comprises an ablation element at the distal end of the catheter body.
32. The instrument of claim 31 wherein the ablation element is a contact heating element.
33. The instrument of claim 31 wherein the instrument further comprises an expandable element and the ablation element is coupled to at least a portion of the expandable element.
34. The instrument of claim 31 wherein the ablation element comprises at least one electrode adapted to couple to an electric current source.
35. The instrument of claim 34 wherein the electrode is coupled to a radio frequency electric current source.
36. The instrument of claim 31 wherein the ablation element is a cryogenic ablation element.
37. The instrument of claim 31 wherein the ablation element is an ultrasound ablation element.
38. The instrument of claim 31 wherein the ablation element is adapted to be positioned at a location where a pulmonary vein extends from an atrium.
39. The instrument of claim 19 wherein the contact sensor comprises at least one optic fiber for collecting reflected light.
40. The instrument of claim 19 wherein the contact sensor comprises a plurality of optic fibers for illuminating light to different directions.
41. A cardiac ablation instrument comprising:
a first catheter body adapted for disposition within a heart having at least one lumen therein and comprising at least one anchorage element which can be deployed at the desired location to contact a cardiac structure and secure the device in place; and
a radiant energy emitter movable within a lumen of the first catheter body such that it can be disposed at the desired location and deliver radiant energy through a transmissive region of the instrument to a target tissue site.
42. The instrument of claim 41 wherein the anchorage element is an anchor balloon adapted for inflation within a pulmonary vein to secure the instrument at a desired location.
43. The instrument of claim 41, wherein the radiant energy emitter is slidably disposed within a lumen of the first catheter body and the instrument further comprises a translatory mechanism for positioning the emitter at a selected location within the first catheter body.
44. The instrument of claim 41, wherein the radiant energy emitter further comprises a light transmitting optical fiber adapted to receive radiant energy from a light source and a light emitting tip at a distal end of the fiber for emitting light.
45. The instrument of claim 44, wherein the light emitting tip further comprises a beam forming optical waveguide for projecting an annular beam of light.
46. The instrument of claim 44, wherein the light emitting tip further comprises a light diffusing element.
47. The instrument of claim 44, wherein the instrument further comprises a light source for generating photoablative radiation at desired wavelengths ranging from between about 800 nm and about 1000 nm
48. The instrument of claim 44, wherein the instrument further comprises a light source for generating photoablative radiation at a desired wavelength ranging from about 915 nm to about 980 nm.
49. The instrument of claim 41, wherein the radiant energy emitter comprises an ultrasound generator.
50. The instrument of claim 41, wherein the radiant energy emitter comprises a microwave generator.
51. The instrument of claim 41 wherein the instrument further comprises a second catheter body with an inner channel, configured for coupling to the first catheter body via the channel such that the second catheter body can be passed over the first catheter body into a position within the heart, and having an inflatable projection balloon which be deployed to clear blood from a surrounding region within the heart.
52. The instrument of claim 41 wherein the instrument further comprises a contact sensor.
53. The instrument of claim 42 wherein the instrument further comprises at least one optical sensor within the instrument for receiving reflected light.
54. The instrument of claim 53 wherein the instrument further comprises a source of illumination for illuminating a region surrounding the instrument and inducing reflected light that can be collected by the optical sensor.
55. The instrument of claim 53 wherein the instrument further comprises a detector capable of distinguishing at least two wavelengths of reflected light.
56. A method of ablating cardiac tissue, comprising:
positioning a guide wire in proximity to a target region of cardiac tissue;
coupling a first catheter having at least one lumen to the positioned guide wire via the lumen such that the first catheter can be passed over the guide wire into a position within the heart;
removing the guide wire and replacing it with a radiant energy emitter slidable movable within a lumen of the first catheter such that it can be disposed at the desired location; and
activating the radiant energy emitter to deliver radiant energy through a transmissive region of the first catheter to the target tissue region to ablate tissue and form a conduction block.
57. The method of claim 56 wherein the step of activating the radiant energy emitter further comprises activating a light emitting element to expose the target region to light energy to induce photocoagulation of cardiac tissue within the target region.
58. The method of claim 57 wherein the step of activating the radiant energy emitter further comprises activating a light emitting element to expose the target region to light energy to induce a continuous lesion in the cardiac tissue.
59. The method of claim 57 wherein the step of activating the radiant energy emitter further comprises activating a light emitting element having a beam-forming optical waveguide to expose the target region to an annular beam of light energy to induce a circumferential lesion in cardiac tissue.
60. The method of claim 57, the step of activating the radiant energy emitter further comprises activating a light emitting element generating photoablative radiation at a desired wavelength ranging from about 800 nm to about 1000 nm
61. The method of claim 57, the step of activating the radiant energy emitter further comprises activating a light emitting element generating photoablative radiation at a desired wavelength ranging from about 915 nm to about 980 nm.
62. The method of claim 56, the step of activating the radiant energy emitter further comprises activating an ultrasound emitting element to expose the target region to acoustic energy to induce photocoagulation of cardiac tissue within the target region.
63. The method of claim 56, the step of activating the radiant energy emitter further comprises activating a radiation emitting element to expose the target region to at least one form of radiant energy selected from the group consisting of microwave, x-ray, gamma-ray and ionizing radiation to induce photocoagulation of cardiac tissue within the target region.
64. The method of claim 56 wherein the method further comprises inflating a projection balloon to clear blood from a transmission pathway between the energy emitter and a target region of cardiac tissue.
65. The method of claim 56 wherein the method further comprises determining whether a clear transmission path has been established between the radiant energy emitter and the target tissue based on reflectance measurements by an optical sensor disposed within the lumen of the first catheter.
66. The method of claim 65 wherein the method further comprises measuring at least two different wavelengths of reflected light collected by the optical sensor to determine whether a projection path exists.
67. A method of treating atrial fibrillation, comprising:
positioning a distal portion of an ablation instrument in proximity to one or more pulmonary veins, the instrument having a hollow housing and an independently positionable energy emitter within the distal portion, the distal portion being transmissive to radiant energy; and
activating the energy emitter to transmit energy through the housing to form an annular lesion in proximity to the one or more pulmonary veins.
68. The method of claim 67, the step of activating the radiant energy emitter further comprises activating a radiation emitting element to expose the target region to at least one form of radiant energy selected from the group consisting of light, ultrasound, microwave, x-ray, gamma-ray and ionizing radiation to induce photocoagulation of cardiac tissue within a target region.
69. The method of claim 67 wherein the method further comprises
inflating a projection balloon to clear blood from a transmission pathway between the energy emitter and a target region of cardiac tissue.
70. The method of claim 69 wherein the method further comprises determining whether a clear transmission path exists between the energy emitter and the target region based on reflectance measurements by an optical sensor disposed within the ablation instrument.
71. The method of claim 70 wherein the method further comprises measuring at least two different wavelengths of reflected light collected by the optical sensor to determine whether a projection path has been established.
72. The method of claim 67 wherein the step of activating the energy emitter further comprises activating a light emitting element to expose the target region to light energy to induce photocoagulation of cardiac tissue within the target region.
73. The method of claim 67 wherein the step of activating the radiant energy emitter further comprises activating a light emitting element to expose the target region to light energy to induce a continuous lesion in the cardiac tissue.
74. The method of claim 67 wherein the step of activating the energy emitter further comprises activating a light emitting element having a beam-forming optical waveguide to expose the target region to an annular beam of light energy to induce a circumferential lesion in cardiac tissue.
75. The method of claim 67, the step of activating the energy emitter further comprises activating a light emitting element generating photoablative radiation at a desired wavelength ranging from about 800 μm to about 1000 nm
76. The method of claim 67, the step of activating the energy emitter further comprises activating a light emitting element generating photoablative radiation at a desired wavelength ranging from about 915 nm to about 980 nm.
77. The method of claim 67, the step of activating the energy emitter further comprises activating an ultrasound emitting element to expose the target region to acoustic energy to induce photocoagulation of cardiac tissue within the target region.
78. The method of claim 67, the step of activating the energy emitter further comprises activating a radiation emitting element to expose the target region to at least one form of radiant energy selected from the group consisting of microwave, x-ray, gamma-ray and ionizing radiation to induce photocoagulation of cardiac tissue within the target region.
Description
    CROSS-REFERENCE TO RELATED APPLICATIONS
  • [0001]
    This application is a continuation-in part of U.S. patent application Ser. No. 09/924,393, filed on Aug. 7, 2001, which is a continuation-in-part of U.S. patent application Ser. No. 09/390,964, filed Sep. 7, 1999, now U.S. Pat. No. 6,270,492 issued Aug. 7, 2001, which is a continuation-in-part of U.S. patent application Ser. No. 08/991,130, filed Dec. 16, 1997, now U.S. Pat. No. 5,947,595 issued Sep. 7, 1999, which is a continuation-in-part of U.S. patent application Ser. No. 08/827,631, filed Apr. 10, 1997, now U.S. Pat. No. 5,908,415 issued Jun. 1, 1999, which is a continuation of U.S. patent application Ser. No. 08/303,605, filed Sep. 9, 1994, abandoned.
  • [0002]
    This application is also a continuation-in-part of U.S. patent application Ser. No. 09/616,275 filed Jul. 14, 2000, which is a continuation-in-part of U.S. patent application Ser. No. 09/602,420 filed Jun. 23, 2000, which is a continuation-in-part of U.S. patent application Ser. No. 09/357,355, filed on Jul. 14, 1999, now U.S. Pat. No. 6,423,055 issued Jul. 22, 2002. The teachings of all of these prior related applications are hereby expressly incorporated by reference.
  • BACKGROUND OF THE INVENTION
  • [0003]
    The present invention relates to ablation instruments for ablation of tissue for the treatment of diseases, and, in particular, to percutaneous instruments employing radiant energy. Methods of ablating tissue using radiant energy are also disclosed. The instruments can be used, for example, in the treatment of cardiac conditions such as cardiac arrhythmias.
  • [0004]
    Cardiac arrhythmias, e.g., fibrillation, are irregularities in the normal beating pattern of the heart and can originate in either the atria or the ventricles. For example, atrial fibrillation is a form of arrhythmia characterized by rapid randomized contractions of atrial myocardium, causing an irregular, often rapid ventricular rate. The regular pumping function of the atria is replaced by a disorganized, ineffective quivering as a result of chaotic conduction of electrical signals through the upper chambers of the heart. Atrial fibrillation is often associated with other forms of cardiovascular disease, including congestive heart failure, rheumatic heart disease, coronary artery disease, left ventricular hypertrophy, cardiomyopathy or hypertension.
  • [0005]
    Various techniques have been proposed for the treatment of arrhythmia. Although these procedures were originally performed with a scalpel, various other techniques have also been developed to form lesions. Collectively, these treatments are referred to as “ablation.” In non-surgical ablations, the tissue is treated, generally with heat or cold, to cause coagulation and/or tissue necrosis (i.e., cell destruction). In each of these techniques, cardiac muscle cells are replaced with scar tissue which cannot conduct normal electrical activity within the heart.
  • [0006]
    For example, the pulmonary vein has been identified as one of the origins of errant electrical signals responsible for triggering atrial fibrillation. In one known approach, circumferential ablation of tissue within the pulmonary veins or at the ostia of such veins has been practiced to treat atrial fibrillation. Similarly, ablation of the region surrounding the pulmonary veins as a group has also been proposed. By ablating the heart tissue (typically in the form linear or curved lesions) at selected locations, electrical conductivity from one segment to another can be blocked and the resulting segments become too small to sustain the fibrillatory process on their own.
  • [0007]
    Several types of ablation devices have recently been proposed for creating lesions to treat cardiac arrhythmias, including devices which employ electrical current (e.g., radiofrequency “RF”) heating or cryogenic cooling. Such ablation devices have been proposed to create elongated lesions that extend through a sufficient thickness of the myocardium to block electrical conduction. Many of the recently proposed ablation instruments are percutaneous devices that are designed to create such lesions from within the heart. Such devices are positioned in the heart by catheterization of the patient, e.g., by passing the ablation instrument into the heart via a blood vessel, such as the femoral vein.
  • [0008]
    Devices that rely upon resistive or conductive heat transfer can be prone to serious post-operative complications. In order to quickly perform an ablation with such “contact” devices, a significant amount of energy must be applied directly to the target tissue site. In order to achieve transmural penetration, the surface that is contacted will experience a greater degree of heating (or freezing). For example, in RF heating of the heart wall, a transmural lesion requires that the tissue temperature be raised to about 50° C. throughout the thickness of the wall. To achieve this, the temperature at the contact surface will typically be raised to greater than 100° C. In this temperature regime, there is a substantial risk of tissue destruction (e.g., due to water vaporization micro-explosions or due to carbonization). Charring of the surface of the heart tissue, in particular, can lead to the creation of blood clots on the surface and post-operative complications, including stroke. Even if structural damage is avoided, the extent of the lesion (i.e., the width of the ablated zone) on the surface that has been contacted will typically be greater than necessary.
  • [0009]
    Ablation devices that do not require direct contact have also been proposed, including acoustic and radiant energy. Acoustic energy (e.g., ultrasound) is poorly transmitted into tissue (unless a coupling fluid is interposed). Laser energy has also been proposed but only in the context of devices that focus light into a scalpel-like point or similar high intensity spot pattern. When the light energy is delivered in the form of a focused spot, the process is inherently time consuming because of the need to expose numerous spots to form a continuous linear or curved lesion.
  • [0010]
    In addition, existing instruments for cardiac ablation also suffer from a variety of design limitations. The shape of the heart muscle adds to the difficulty in accessing cardiac structures, such as the pulmonary veins on the anterior surface of the heart. Typically, percutaneous devices are positioned with the assistance of a guide wire, which is first advanced into heart. In one common approach, described, for example, in U.S. Pat. No. 6,012,457 issued to Lesh on Jan. 11, 2000 and in International Application Pub. No. WO 00/67656 assigned to Atrionix, Inc, a guide wire or similar guide device is advanced through the left atrium of the heart and into a pulmonary vein. A catheter instrument with an expandable element is then advanced over the guide and into the pulmonary vein where the expandable element (e.g., a balloon) is inflated. The balloon structure also includes a circumferential ablation element, e.g., an RF electrode carried on the outer surface of the balloon, which performs the ablation procedure. The balloon must be large enough and sufficiently rigid to hold the electrode in contact with the inner surface of the pulmonary vein for the length of the procedure. Moreover, because the lesion is formed by an ablation element carried on the surface of the balloon element, the balloon shape inherently limits the locations where a lesion can be formed, i.e., the lesion must be formed at least partially within the pulmonary vein.
  • [0011]
    In another approach described in U.S. Pat. No. 6,235,025 issued to Swartz et al. on May 22, 2001, a guide wire is again used to percutaneously access a pulmonary vein and a catheter is again slid over the guide to a position within the pulmonary vein. The catheter device includes two spaced-apart balloons, which are inflated in the vein (or in the vein and at its mouth). The space between the two balloons can then be filled with a conductive fluid to delivery RF energy (or, alternatively, ultrasound) to the vein and thereby induce a conduction block in the blood vessel by tissue ablation. With the Swartz et al. device, like the Lesh device, the region where tissue ablation can occur is limited by the design. Because two balloons must seal a space that is then filled with an ablative fluid, the lesion is necessarily formed within the pulmonary vein.
  • [0012]
    Ablation within the pulmonary vein can result in complications. Overtreatment deep within a vein can result in stenosis (closure of the vein itself), necrosis or other structural damage, any of which can necessitate immediate open chest surgery.
  • [0013]
    A major limitation in the prior art percutaneous designs is the lack of site selectability. Practically speaking, each prior art percutaneous instrument is inherently limited by its design to forming an ablative lesion at one and only one location. For example, when an expandable balloon carrying an RF heating surface on it surface is deployed at the mouth of a vein, the lesion can only be formed at a location defined by the geometry of the device. It is not possible to form the lesion at another location because the heating element must contact the target tissue. Similarly the above-described tandem balloon device can only form a lesion at a location defined by the space between the balloons that is filled with the ablative fluid.
  • [0014]
    Another major limitation in prior art percutaneous designs is their inability to accommodate the actual and quite varied geometry of the heart. The inner surface of the atrium is not regular. In particular, the mouths of the pulmonary veins do not exhibit regularity; they often bear little resemble to conical or funnel-shaped openings. When the expandable, contact heating devices of the prior art encounter irregularly-shaped ostia, the result can be an incompletely formed (non-circumferential) lesion.
  • [0015]
    Accordingly, a percutaneous ablation device that allowed the clinician to select the location of the ablation site would be highly desirable. An instrument that allows a clinician to choose from a number of different lesion locations, especially in creating continuous conduction blocks around pulmonary veins, would satisfy a long felt need in the art.
  • [0016]
    Moreover, the prior art devices typically can not determine whether continuous circumferential contact has been achieved before heating commences. These devices most often rely on post-ablation electrical mapping to determine whether a circumferential lesion has been formed. If electric conduction is still present, the encircling lesion is incomplete and the procedure must be repeated or abandoned.
  • [0017]
    Accordingly, there also exists a need for better surgical ablation instruments that can form lesions with less trauma to the healthy tissue of the heart and greater likelihood of success. A percutaneous system that could determine whether contact has been achieved (or blood has been cleared from the target site) and predict success based on such determinations would represent a significant improvement over the existing designs.
  • SUMMARY OF THE INVENTION
  • [0018]
    Ablation methods and instruments are disclosed for creating lesions in tissue, especially cardiac tissue for treatment of arrhythmias and the like. In one aspect of the invention, percutaneous ablation instruments in the form of coaxial catheter bodies are disclosed having at least one central lumen therein and having one or more balloon structures at the distal end region of the instrument. The balloon structure and catheter bodies are at least partially transmissive to ablative energy. The instruments can further include an energy emitting element, which is independently positionable within the lumen of the instrument and adapted to project ablative energy through a transmissive region of the balloon to a target tissue site. The energy is delivered without the need for contact between the energy emitter and the target tissue because the methods and devices of the present invention do not rely upon conductive or resistive heating. Because the position of the radiant energy emitter can be varied, the clinician can select the location of the desired lesion.
  • [0019]
    In another aspect of the invention, generally applicable to a wide range of cardiac ablation instruments, mechanisms are disclosed for determining whether the instrument has been properly seated within the heart, e.g., whether the device is in contact with a pulmonary vein and/or the atrial surface, in order to form a lesion by heating, cooling or projecting energy. This contact-sensing feature can be implemented by an illumination source situated within the instrument and an optical detector that monitors the level of reflected light. Measurements of the reflected light (or wavelengths of the reflected light) can thus be used to determine whether contact has been achieved and whether such contact is continuous over a desired ablation path.
  • [0020]
    The instruments are especially useful in percutaneous access cardiac surgery for rapid and efficient creation of curvilinear lesions to serve as conduction blocks. The instruments are designed to create lesions in the atrial tissue in order to electrically decouple tissue segments on opposite sides of the lesion while presenting low profiles during percutaneous access and retraction. The instruments of the present invention permit the formation of continuous lesions in the atrial wall tissue of the heart, such that the continuous lesion can surround a organ structure, such as a pulmonary vein, without involving the structure itself.
  • [0021]
    In one embodiment a cardiac ablation instrument is disclosed having a catheter body adapted for disposition within a heart. This catheter body has at least one lumen therein and an expandable, energy-transmitting element which can be deployed at the desired location with or without an anchorage element to contact a cardiac structure and establish a transmission pathway. For example, the expandable element can be a projection balloon that is expandable to fill the space between the energy emitter and the target tissue with an energy-transmissive fluid and, thereby, provide a transmission pathway for projected radiant energy. The instrument further includes a radiant energy delivery element movable within the lumen of the catheter body such that it can be disposed at the desired location and deliver radiant energy through a transmissive region of the instrument to a target tissue site. The instrument can further include additional elements, such fluid delivery ports, to provide a blood-free transmission pathway from the energy emitter to the tissue target.
  • [0022]
    In another embodiment, a cardiac ablation instrument is disclosed having a catheter body adapted for disposition within a heart and at least one anchorage element which can be deployed at the desired location to contact a cardiac structure and secure the device in place. The instrument again includes a radiant energy delivery element movable within the lumen of the catheter body such that it can be disposed at the desired location and deliver radiant energy through a transmissive region of the instrument to a target tissue site. A projection balloon can again be employed, alone or together with fluid releasing mechanisms, to provide a blood-free transmission pathway from the energy emitter to the tissue target.
  • [0023]
    Mechanisms are disclosed for determining whether the ablation instruments of the present invention have been properly seated within the heart to form a lesion. For example, if a projection balloon is employed to provide a clear transmission pathway from a radiant energy emitter to the target tissue, the mechanisms of the present invention can sense whether contact has been achieved between the balloon and the target tissue (and/or whether the pathway for projection of radiant energy has been otherwise cleared of obstructions). In one embodiment, this contact-sensing feature can be implemented by an illumination fiber situated within the instrument and an optical detector fiber (or fiber assembly) that monitors the level of reflected light. Measurements of the reflected light (or wavelengths of the reflected light) can thus be used to determine whether contact has been achieved between the projecxtion balloon and the target tissue, whether blood has been cleared from any gaps and whether a clear and continuous transmission pathway has been established over a desired ablation path.
  • [0024]
    In a further aspect of the invention, percutaneous instruments are disclosed that can achieve rapid and effective photoablation through the use of tissue-penetrating radiant energy. It has been discovered that radiant energy, e.g., projected electromagnetic radiation or ultrasound, can create lesions in less time and with less risk of the adverse types of surface tissue destruction commonly associated with prior art approaches. Unlike instruments that rely on thermal conduction or resistive heating, controlled penetrating radiant energy can be used to simultaneously deposit energy throughout the full thickness of a target tissue, such as a heart wall, even when the heart is filled with blood. Radiant energy can also produce better defined and more uniform lesions.
  • [0025]
    The use of radiant energy, in conjunction with catheter structures that are substantially transparent to such radiation at the therapeutic wavelengths, is particularly advantageous in affording greater freedom in selecting the location of the lesion, e.g., the site is no longer limited to the pulmonary vein itself. Because the energy can be projected onto the tissue, a ring-like lesion can be formed in atrial tissue at a distance from the vein, thereby reducing the potential for stenosis and/or other damage to the vein itself.
  • [0026]
    It has also been discovered that infrared radiation is particularly useful in forming photoablative lesions. In certain preferred embodiments, the instruments emit radiation at a wavelength in a range from about 800 nm to about 1000 nm, and preferably emit at a wavelength in a range of about 915 nm to about 980 nm. Radiation at a wavelength of 915 nm or 980 nm is commonly preferred, in some applications, because of the optimal absorption of infrared radiation by cardiac tissue at these wavelengths.
  • [0027]
    In another embodiment, focused ultrasound energy can be used to ablate cardiac tissue. In certain preferred embodiments, an ultrasound transducer can be employed to transmit frequencies within the range of about 5 to about 20 MHz, and preferably in some applications within the range of about 7 MHz to about 10 MHz. In addition, the ultrasonic emitter can include focusing elements to shape the emitted energy into an annular beam.
  • [0028]
    However, in certain applications, other forms of radiant energy can also be useful including, but not limited to, other wavelengths of light, other frequencies of ultrasound, x-rays, gamma-rays, microwave radiation and hypersound.
  • [0029]
    In the case of radiant light, the energy delivering element can include a light transmitting optical fiber adapted to receive ablative radiation from a radiation source and a light emitting tip at a distal end of the fiber for emitting radiation. The light delivering element can be slidably disposed within an inner lumen of the catheter body and the instrument can further include a translatory mechanism for disposing the tip of the light delivering element at one or more of a plurality of locations with the catheter. Moreover, by moving the energy-projecting tip assembly within the catheter, the diameter of the projected ring of energy can be readily varied, thereby permitting the clinician control over the location (and size) of the lesion to be formed.
  • [0030]
    Optionally, a fluid can be disposable between the radiant energy delivery element and the target region. In one preferred embodiment a “projection balloon” is filled with a radiation-transmissive fluid so that radiant energy from the energy emitter can be efficiently pass through the instrument to the target region. The fluid can also be used to cool the energy emitter. In certain applications, it can be desirable to used deuterium oxide (so-called “heavy water”) as a balloon-filling fluid medium because of its loss absorption characteristics vis-a-vis infrared radiation. In other applications, the inflation fluid can be water or saline.
  • [0031]
    It can also be desirable to employ an “ablative fluid” outside of the instrument (e.g., between the balloon and the target region) to ensure efficient transmission of the radiant energy when the instrument is deployed. An “ablative fluid” in this context is any fluid that can serve as a conductor of the radiant energy. This fluid can be a physiologically compatible fluid, such as saline, or any other non-toxic aqueous fluid that is substantially transparent to the radiation. In one preferred embodiment, the fluid is released via one or more exit ports in the housing and flows between the projection balloon and the surrounding tissue, thereby filling any gaps where the balloon does not contact the tissue. The fluid can also serve an irrigation function by displacing any blood within the path of the radiant energy, which could otherwise interfere because of the highly absorptive nature of blood with respect to radiant light energy.
  • [0032]
    Similarly, if the radiant energy is acoustic, aqueous coupling fluids can be used to ensure high transmission of the energy to the tissue (and likewise displace blood that might interfere with the radiant acoustic energy transfer).
  • [0033]
    The ablative fluids of the present invention can also include various other adjuvants, including, for example, photosensitizing agents, pharmacological agents and/or analgesics.
  • [0034]
    As noted above, contact sensing mechanisms are also disclosed to assist the clinician in selecting the location of the lesion and in ensuring a selected location will result in the formation of a continuous (e.g., vein encircling) lesion. In one embodiment the sensor employs a plurality of reflection sensors that indicate whether or not a clear transmission pathway has been established (e.g., whether the projection balloon is properly seated and any gaps in contact have been filled by an ablative fluid).
  • [0035]
    The coaxial catheter instruments disclosed herein are of particular use in percutaneous applications whereby a balloon catheter with an ablative light or ultrasound projecting assembly can be disposed within a patient's heart. In another aspect of the invention, dual, coaxial balloon structures are disclosed, having both a projection balloon and an anchoring balloon to assist in the properly disposition of the instrument.
  • [0036]
    In the dual, coaxial, catheter embodiment, the catheter instrument can include at least one expandable anchor balloon disposed about, or incorporated into an inner catheter body designed to be slid over a guidewire. This anchor balloon is generally or substantially sealed and serves to position the device within a lumen, such as a pulmonary vein. The anchor balloon structure, when filled with fluid, expands and is engaged in contact with tissue, e.g., the inner surface of a pulmonary vein.
  • [0037]
    A second catheter carrying the projection balloon can then be slid over the first (anchor balloon) catheter body and inflated within the heart, e.g., within the left atrium and adjacent to the pulmonary vein where the anchor balloon has already been placed. The expanded projection balloon thus defines a staging from which to project radiant energy in accordance with the invention. An energy emitting element can then be introduced via an inner lumen to project radiant energy, e.g., infrared light or ultrasound, through the coaxial catheter bodies and the projection balloon to form a lesion at the target treatment site. The instrument can also include an irrigation mechanism for delivery of an ablative fluid at the treatment site. In one embodiment, irrigation is provided by a sheath, partially disposed about the projecting balloon, and provides irrigation at a treatment site (e.g. so that blood can be cleared from an ablation site).
  • [0038]
    Both the anchor and projection balloon structures can be deflated by applying a vacuum which removes the fluid from the balloons. Once fully deflated, the coaxial instrument can be removed from the body lumen either as an ensemble, or as individual elements (starting with the innermost element). Alternatively, the energy delivery element can be removed (via an inner lumen balloon structure), followed by the projection balloon catheter and then the anchor balloon catheter.
  • [0039]
    The invention can also be used in conjunction with one or more mapping catheters. For example the guide wire element (and/or the anchorage balloon catheter) can be removed and replaced with a mapping catheter before and/or after the lesion is formed to determine whether the ablation has been successful in stopping errant electrical signals from propagating in the atrial wall tissue.
  • [0040]
    The present invention also provides methods for ablating tissue. One method of ablating tissue comprises positioning a radiant energy emitting element at a distance from a target region of tissue, providing a blood-free transmission pathway between the emitter and the target region, and then projecting radiant energy to expose the target region and induce a lesion.
  • [0041]
    In one method according to the invention, a guide wire is first inserted into the femoral vein and advanced through the inferior vena cava, and into the right atrium, or, if required, it is guided into the left atrium via an atrial septal puncture. In either event, the guide wire is advanced until it enters a pulmonary vein. The first catheter body is then slid over the guide wire until its anchorage element, e.g., the anchor balloon, is likewise advanced into the pulmonary vein. The anchor balloon is then inflated via an inflation fluid to secure the first catheter body. Next, a second catheter body is advanced, coaxially, over the first catheter body, carrying a projection balloon to the treatment site. Once the projection balloon is proximate to the target tissue ablation site, it can likewise be inflated. In addition, a solution can be injected through the instrument to force blood and/or body fluids away from the treatment site.
  • [0042]
    The guide wire is then removed and replaced with the radiant energy emitter, which is positioned to deliver radiant energy through the projection balloon to induce tissue ablation. The methods of the present invention can further include a position sensing step to assist the clinician in selecting the location of the lesion and in ensuring a selected location will result in the formation of a continuous (e.g., vein encircling) lesion. In one embodiment, one or more reflection sensors are activated to determine whether a clear transmission pathway has been established (e.g., whether the projection balloon is properly seated and any gaps in contact have been filled by an ablative fluid).
  • [0043]
    Following the ablation procedure, the radiant energy emitter is removed from the central lumen of the first catheter body. The anchor balloon can then be deflated by applying a vacuum that removes the inflation fluid from the balloon. A syringe or other known methods can be used to remove the fluid. In one embodiment, the anchor balloon can be deflated first and removed along with the first (inner) catheter body. The first catheter body can then be replaced with a mapping catheter. Once the mapping electrode is advanced into the pulmonary vein, the projection balloon can be likewise deflated and the second catheter body removed, thus leaving only the mapping catheter in place. The mapping catheter can then be activated to determine whether a conduction block has been achieved. If the ablation is successful, the mapping catheter can be removed. If conduction is still present, the procedure can be repeated, for example, by reintroducing the second catheter body, followed by removal of the mapping catheter, and repositioning the anchor balloon and the radiant energy emitter.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0044]
    The invention will be more fully understood from the following detailed description taken in conjunction with the accompanying drawings, in which like reference numerals designate like parts throughout the figures, and wherein:
  • [0045]
    FIG. 1 is a schematic, cross-sectional view of a coaxial catheter ablation instrument according to the invention;
  • [0046]
    FIG. 2 is a schematic illustration of an initial step in performing ablative surgery with radiant energy according to the invention, in which a guide wire is introduced into a heart and passed into a pulmonary vein;
  • [0047]
    FIG. 3 is a schematic illustration of another step in performing ablative surgery with radiant energy according to the invention, in which a first catheter, carrying an anchoring balloon structure, is slid over the guide wire;
  • [0048]
    FIG. 4 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which an anchoring balloon structure is inflated;
  • [0049]
    FIG. 5 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which a second catheter, carrying a projection balloon element, is slid over the first catheter body;
  • [0050]
    FIG. 6 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which the projection balloon element of the second catheter is inflated to define a projection pathway for radiant energy ablation of cardiac tissue;
  • [0051]
    FIG. 7 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which the guide wire is removed and replaced by a radiant energy emitter located remote from the lesion site but in a position that permits projection of radiant energy onto a target region of the heart;
  • [0052]
    FIG. 8 is a schematic illustration of a step in performing ablative surgery according to the invention, in which the radiant energy emitter is positioned to form a lesion at a defined location;
  • [0053]
    FIG. 9 is a schematic illustration of an alternative step in performing ablative surgery according to the invention, in which the radiant energy emitter is positioned to form a lesion at a different defined location;
  • [0054]
    FIG. 10 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which radiant energy emitter is removed and the anchor balloon element of the first catheter is deflated to permit removal of the first catheter body;
  • [0055]
    FIG. 11 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which the first catheter is replaced by a mapping electrode;
  • [0056]
    FIG. 12 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which the projection balloon is deflated and removed while the mapping electrode remains in place to verify the formation of an electrical conduction block;
  • [0057]
    FIG. 13 is a schematic illustration of alternative approach to ablative surgery with radiant energy according to the invention, in which a catheter carrying an projection balloon structure, is slid over a guide wire without first introducing an anchoring balloon catheter;
  • [0058]
    FIG. 14 is a schematic illustration of a further step in performing ablative surgery with the embodiment illustrated in FIG. 13, in which the projection balloon element is inflated to define a projection pathway for radiant energy ablation of cardiac tissue;
  • [0059]
    FIG. 15 is a schematic illustration of a further step in performing ablative surgery with the embodiment illustrated in FIG. 13, in which the guide wire is removed and replaced by a radiant energy emitter located remote from the lesion site but in a position that permits projection of radiant energy onto a target region of the heart;
  • [0060]
    FIG. 16 is a schematic illustration of a system according to the invention in which an asymmetric vein mouth is encountered and further showing how the position of the radiant energy emitter can be adjusted to sense contact and select a location; FIG. 16A illustrates how a continuous, vein-encircling lesion can be formed by two partially-encircling lesions;
  • [0061]
    FIG. 17 is a schematic illustration of one embodiment of a radiant light energy emitter according to the invention;
  • [0062]
    FIG. 18 is a schematic illustration of another embodiment of a radiant light energy emitter according to the invention;
  • [0063]
    FIG. 19 is a schematic illustration of an alternative embodiment of a radiant energy emitter according to the invention employing ultrasound energy;
  • [0064]
    FIG. 20 is a schematic illustration of an alternative embodiment of a radiant light energy emitter according to the invention employing microwave or ionizing radiation;
  • [0065]
    FIG. 21 is a schematic cross-sectional illustration of one embodiment of a contact sensor according to the invention;
  • [0066]
    FIG. 22 is an end view, schematic illustration of the contact sensor elements shown in FIG. 21;
  • [0067]
    FIG. 23 is a schematic view of a contact heating ablation device employing the contacting sensing apparatus of the present invention; FIG. 23A is a schematic view of a croygenic ablation device employing the contacting sensing apparatus of the present invention; FIG. 23B is a schematic view of a ultrasound heating ablation device employing the contacting sensing apparatus of the present invention and
  • [0068]
    FIG. 24 is a schematic illustration of a mechanism for positioning the radiant energy emitter at a selected location relative to the target tissue region.
  • DETAILED DESCRIPTION
  • [0069]
    FIG. 1 provides a schematic, cross-sectional view of a coaxial catheter ablation instrument 10 according to the invention, including a first, inner catheter 12 having an elongate body 14 and an anchor balloon 16, inflatable via one or more ports 18. A fluid for inflating the anchor balloon can be delivered through a passageway (not shown) within the elongate body or via one or more of the lumens of the device, as discussed in more detail below. The device can further include a second, coaxial, outer catheter 20 having an elongate body 24 and a projection balloon 26 inflatable via one or more ports 22. The instrument is preferably designed such that upon anchorage of the anchor balloon 16 within the heart (e.g., within a pulmonary vein), the projection balloon can be inflated such a shoulder portion 50 of the balloon 26 will be urged into close proximity with a target region 52 of cardiac tissue (e.g. an annular region of the atrial heart wall surrounding the ostium of a pulmonary vein).
  • [0070]
    The instrument can also include one or more ports 36 (in fluid communication with either the first catheter 12 or second catheter 20, or both) for delivering ablative fluid to the target region. Preferably, the ablative fluid is an energy transmissive medium, which helps deliver light, radiation or acoustic energy from a radiant energy source to a target tissue region. The ablative fluid also serves to clear blood from the vicinity of the instrument and compensate for irregularities in the shape of the heart that might otherwise compromise the seating of the instrument. The ablative fluid thus provides a clear transmission pathway external to the balloon.
  • [0071]
    Within the projection balloon 26 a radiant energy emitter 40 can be disposed remotely from the target tissue (e.g., within a central lumen of the coaxial catheters 12, 20). In one embodiment, the radiant energy source includes at least one optical fiber 42 coupled to a distal light projecting, optical element 44, which cooperate to project ablative light energy through the instrument to the target site. The catheter bodies, projection balloon and inflation/ablation fluids are all preferably substantially transparent to the radiant energy at the selected wavelength to provide a low-loss transmission pathway from the projection element 44 to the target.
  • [0072]
    FIG. 2 is a schematic illustration of an initial step in performing ablative surgery with radiant energy according to the invention, in which a guide wire 6 is introduced into a heart 2 and passed into a pulmonary vein 4. FIG. 3 illustrates the next step in performing ablative surgery according to the invention, in which a first catheter 12, carrying an anchoring balloon structure 16, is slid over the guide wire 6. This first catheter 12 can further include at least one internal fluid passageway (not shown) for inflation of the balloon 12, which is sealed to the body of the catheter 14 by distal seal 15 and proximal seal 17, such that the introduction of an inflation fluid into the balloon 16 can inflate the balloon as shown in FIG. 4. For further details on anchoring balloon structures, see commonly owned, U.S. patent application Ser. No. 09/616,303 filed Jul. 14, 2000 entitled “Catheter Anchoring Balloon Structure with Irrigation,” the disclosures of which are hereby incorporated by reference.
  • [0073]
    FIG. 5 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which a second catheter 20, likewise having a elongated body 24 and carrying a projection balloon element 26, is slid over the first catheter body 14. This second catheter 20 also includes at least one internal fluid passageway (not shown) for inflation of the balloon 26, which is sealed to the body 24 of the catheter 20 by distal seal 21 and proximal seal 22, such that the introduction of an inflation fluid into the balloon 26 can inflate the balloon as shown in FIG. 6.
  • [0074]
    Thus, FIG. 6 illustrates how which the projection balloon 26 of the second catheter 20 can be deployed and inflated to define a projection pathway for radiant energy ablation of cardiac tissue. Second catheter body 24 has an inner lumen 27 sized to pass over the inner catheter body 14. Once it is positioned in the heart, the projection balloon of the second catheter is then inflated. The expanded projection balloon defines a staging through which radiant energy can be projected in accordance with the invention. In one preferred embodiment, the projection balloon is filled with a radiation-transmissive fluid so that radiant energy from an energy emitter can be efficiently pass through the instrument to a target region of cardiac tissue.
  • [0075]
    The projection balloons described herein can be preshaped to form a parabolic like shape. This can be accomplished, for example, by shaping and melting a TEFLONŽ film in a preshaped mold to effect the desired form. The projection balloons and sheaths of the present invention can be made, for example, of thin wall polyethylene teraphthalate (PET) with a thickness of the membranes of about 5-50 micrometers.
  • [0076]
    It should be noted that it is not necessary (and in some cases, not desirable) for the projection balloon 26 to contact the target tissue in order to ensure radiant energy transmission. One purpose of the projection balloon is simply to clear a volume of blood away from the path of the energy emitter. With reference again to FIG. 1, an ablative fluid 29 can be employed outside of the instrument (e.g., between the balloon 26 and the target region 52) to ensure efficient transmission of the radiant energy when the instrument is deployed. The ablative fluid in this context is any fluid that can serve as a conductor of the radiant energy. This ablative fluid can be a physiologically compatible fluid, such as saline, or any other non-toxic aqueous fluid that is substantially transparent to the radiation. As shown in FIG. 1, the fluid 29 can be released via one or more exit ports 36 in the first catheter body 14 (and/or second catheter body 24) to flow between the projection balloon 26 and the surrounding tissue, thereby filling any gaps where the balloon 26 does not contact the tissue. The fluid 29 can also serve an irrigation function by displacing any blood within the path of the radiant energy, which could otherwise interfere with the radiant light energy transmission to the target region 52.
  • [0077]
    For alternative designs for delivery of ablative and/or irrigation fluids, see commonly-owned, U.S. patent application Ser. No. 09/660,601, filed Sep. 13, 2000 entitled “Balloon Catheter with Irrigation Sheath,” the disclosures of which are hereby incorporated by reference. For example, in one embodiment described in patent application Ser. No. 09/660,601, the projection balloon can be partially surrounded by a sheath that contains pores for releasing fluid near or at the target ablation site. One of ordinary skill in the art will readily appreciate that such pores can vary in shape and/or size. A person having ordinary skill in the art will readily appreciate that the size, quantity, and placement of the fluid ports of various designs can be varied to provide a desired amount of fluid to the treatment site.
  • [0078]
    FIG. 7 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which the guide wire is removed and replaced by a energy emitter 40 located remote from the desired lesion site 52 but in a position that permits projection of radiant energy onto a target region of the heart. The energy emitter can be introduced into the instrument via the lumen 13 of the inner catheter. In the illustrated embodiment, the energy emitter 40 is a radiant energy emitter and includes at least one optical fiber 42 coupled to a distal light projecting, optical element 43, which cooperate to project ablative light energy through the instrument to the target site. In one preferred embodiment, optical element is a lens element capable of projecting an annular (ring-shaped) beam of radiation, as described in more detail in commonly owned U.S. Pat. No. 6,423,055 issued Jul. 22, 2002, herein incorporated by reference.
  • [0079]
    FIGS. 8 and 9, taken together, illustrate an advantageous feature of the present invention, namely, the ability to select the location a lesion independent of the instrument design. Because the radiant energy emitter does not require contact with a target tissue region and is, in fact, decoupled from the rest of the instrument, the present invention permits the clinician to select a desired target region by simply moving the emitter (e.g., within the lumen 14 of the first catheter 12). As shown in FIG. 8, the radiant energy emitter can be positioned to form a wide circumferential lesion (when the shape of the pulmonary vein ostium warrants such a lesion) by positioning the radiant energy emitter at the rear of the projection balloon—at a distance from the target tissue. Alternatively, a smaller diameter lesion can be formed by positioning the radiant energy emitter closer to the front of the project balloon, as shown in FIG. 9. Such a lesion can be preferably when the geometer of the vein ostium presents a more gradual change in diameter, as shown. It should be appreciated that it may be desirable to change the intensity of the emitted radiation depending upon the distance it must be projected; thus a more intense radiant energy beam may be desirable in the scheme illustrated in FIG. 8 versus that shown in FIG. 9. The energy emitter 40 and catheter body 24 can each include one or more markers (shown schematically as elements 33 and 35 respectively) to aid in determining the location or tracking movements of the elements. Markers 33 and 35, for example, can be radioopaque lines that can visualized fluoroscopically. Various other marker mechanisms, such as magnetic, capacitive or optical markers, can also be used.
  • [0080]
    FIG. 10 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which radiant energy emitter 40 (shown in FIGS. 7-9) has been removed and the anchor balloon element 16 of the first catheter 12 is deflated to permit removal of the first catheter body 14.
  • [0081]
    In FIG. 11, the first catheter is replaced by a mapping electrode catheter 88 via, for example, the central lumen of the second catheter 20. However, it should be appreciated that more than one lumen can be used to provide separate pathways for these instruments. Once the mapping electrode is positioned within a pulmonary vein, an electrical pulse can be applied to determine whether the lesion formed by the radiant energy emitter (as described above) is sufficient to serve as a conduction block.
  • [0082]
    FIG. 12 is a schematic illustration of a final step in which the projection balloon is deflated and removed while the mapping electrode remains in place to verify the formation of an electrical conduction block. Various techniques for conducting such tests are known by those skilled in the art. In one simple approach, a voltage pulse is applied by a coronary sinus catheter. The mapping, catheter's electrode is touched to the inner wall of the pulmonary vein. If no signal (or a substantially attenuated signal) is detected, a conduction block can thereby be confirmed. It should also be appreciated that the mapping electrode can in some instances be used even before the projection and/or anchor balloons are removed.
  • [0083]
    FIG. 13 is a schematic illustration of an alternative method of performing ablative surgery with radiant energy according to the invention without the need for an anchoring balloon. As shown in FIG. 13, a guide wire 6 can again be introduced into a heart and passed into a pulmonary vein 4. A catheter 20, carrying projection balloon structure 26, is slid over the guide wire 6. This catheter 20 can further include at least one internal fluid passageway (not shown) for inflation of the balloon 26, which is sealed to the body of the catheter 20 by distal seal 21 and proximal seal 22, such that the introduction of an inflation fluid into the balloon 26 can inflate the balloon.
  • [0084]
    FIG. 14 illustrates how the projection balloon 26 can then be inflated to define a projection pathway for radiant energy ablation of cardiac tissue. The expanded projection balloon defines a staging through which radiant energy can be projected in accordance with the invention. In one preferred embodiment, the projection balloon is filled with a radiation-transmissive fluid so that radiant energy from an energy emitter can be efficiently pass through the instrument to a target region of cardiac tissue.
  • [0085]
    The projection balloons described herein can be preshaped to form various shapes (e.g., to assist in seating the instrument at the mouth of a pulmonary vein or at other anatomically defined regions of the heart). As noted above, this can be accomplished, for example, by shaping and melting a TEFLONŽ film in a preshaped mold to effect the desired form. Again, the projection balloons can be made, for example, of thin wall polyethylene teraphthalate (PET) with a thickness of the membranes of about 5-50 micrometers.
  • [0086]
    One purpose of the projection balloon is clear a volume of blood away from the path of the energy emitter. Towards this end, the instrument can further include a fluid releasing mechanism in the form of one or more fluid ports (or a sheath that contains pores for releasing fluid) near or at the target ablation site. Again, the released fluid can serve as an ablative fluid by clearing a transmission pathway for radiant energy.
  • [0087]
    FIG. 15 is a schematic illustration of a further step in performing ablative surgery with the device of FIGS. 13-14, in which the guide wire is removed and replaced by a radiant energy emitter 40 located remote from the desired lesion site 52 but in a position that permits projection of radiant energy onto a target region of the heart. In the illustrated embodiment, the radiant energy emitter 40 includes at least one optical fiber 42 coupled to a distal light projecting, optical element 43, which cooperate to project ablative light energy through the instrument to the target site. In one preferred embodiment, optical element is again a lens element capable of projecting an annular (ring-shaped) beam of radiation, as described in more detail in commonly owned U.S. Pat. No. 6,423,055 issued Jul. 22, 2002, herein incorporated by reference. Alternatively, the radiant energy emitter can be an ultrasound or microwave energy source, as described in more detail below (in connection with FIGS. 19-20).
  • [0088]
    FIG. 16 further illustrates the unique utility of the multi-positionable, radiant energy ablation devices of the present invention in treating the complex cardiac geometries that are often encountered. As shown in the figure, the mouths of pulmonary veins typically do not present simple, funnel-shaped, or regular conical surfaces. Instead, one side of the ostium 4B can present a gentle sloping surface, while another side 4A presents a sharper bend. With prior art, contact-heating, ablation devices, such geometries will result in incomplete lesions if the heating element (typically a resisting heating band on the surface of an expandable element) can not fully engage the tissue of the vein or ostium. Because the position of the heating band of the prior art devices is fixed, when it does not fully contact the target tissue, the result is an arc, or incompletely formed ring-type, lesion that typically will be insufficient to block conduction.
  • [0089]
    FIG. 16 illustrates how the slidably positionable energy emitters of the present invention can be used to avoid this problem. Three potential positions of the emitter 40 are shown in the figure (labeled as “A”, “B” and “C”). As shown, positions A and C may not result in optimal lesions because of gaps between the balloon and the target tissue. Position B, on the other hand, is preferably because circumferential contact has been achieved. Thus, the independent positioning of the energy source relative to the balloon allows the clinician to “dial” an appropriately ring size to meet the encountered geometry. (Although three discrete locations are shown in FIG. 16, it should be clear that emitter can be positioned in many more positions and that the location can be varied in either discrete intervals or continuously, if so desired.)
  • [0090]
    Moreover, in some instances the geometries of the pulmonary vein (or the orientation of the projection balloon relative to the ostium) may be such that no single annular lesion can form a continuous conduction block. Again, the present invention provides a mechanism for addressing this problem by adjustment of the location of the energy emitter to form two or more partially circumferential lesions. As shown in FIG. 16A, the devices of the present invention can form a first lesion 94 and a second lesion 96, each in the form of an arc or partial ring. Because each lesion has a thickness (dependent largely by the amount of energy deposited into the tissue) the two lesions can axially combine, as shown, to form a continuous encircling or circumscribing lesion that blocks conduction.
  • [0091]
    FIG. 17 is a schematic illustration of one embodiment of a radiant energy emitter 40 according to the invention. In one preferred embodiment, the radiant energy is electromagnetic radiation, e.g., coherent or laser light, and the energy emitter 40 projects an hollow cone of radiation that forms an annular exposure pattern upon impingement with a target surface. For example, as shown in FIG. 1, radiant energy emitter 40 can include an optical fiber 42 in communication with an annulus-forming optical waveguide 44 having a concave interior boundary or surface 45. The waveguide 44 passes an annular beam of light to a graded intensity (GRIN) lens 46, which serves to collimate the beam, keeping the beam width the same, over the projected distance. The beam that exits from the distal window 43 of energy emitter 40 will expand (in diameter) over distance, but the energy will remain largely confined to a narrow annular band. Generally, the angle of projection from the central axis of the optical fiber 42 or waveguide 44 will be between about 20 and 45 degrees.
  • [0092]
    The diameter of the annular beam of light will be dependent upon the distance from the point of projection to point of capture by a surface, e.g., a tissue site, e.g., an interstitial cavity or lumen. Typically, when the purpose of the radiant energy projection is to form a transmural cardiac lesion, e.g., around a pulmonary vein, the diameter of the annular beam will be between about 10 mm and about 33 mm, preferably greater than 10 mm, greater than 15 mm, greater than 20 mm, and most preferably, greater than or equal to 23 mm. Typically, angle of projected annular light is between about 20 and about 45 degrees, preferably between about 17 and about 30 degrees, most preferably between about 16 and about 25 degrees.
  • [0093]
    Preferred energy sources for use with the percutaneous ablation instruments of the present invention include laser light in the range between about 200 nanometers and 2.5 micrometers. In particular, wavelengths that correspond to, or are near, water absorption peaks are often preferred. Such wavelengths include those between about 805 nm and about 1060 nm, preferably between about 900 nm and 1000 nm, most preferably, between about 915 nm and 980 nm. In a preferred embodiment, wavelengths around 915 nm or around 980 nm are used during endocardial procedures. Suitable lasers include excimer lasers, gas lasers, solid state lasers and laser diodes. One preferred AlGaAs diode array, manufactured by Spectra Physics, Tucson, Ariz., produces a wavelength of 980 nm.
  • [0094]
    The optical waveguides, as described in above, can be made from materials known in the art such as quartz, fused silica or polymers such as acrylics. Suitable examples of acrylics include acrylates, polyacrylic acid (PAA) and methacrylates, polymethacrylic acid (PMA). Representative examples of polyacrylic esters include polymethylacrylate (PMA), polyethylacrylate and polypropylacrylate. Representative examples of polymethacrylic esters include polymethylmethacrylate (PMMA), polyethylmethacrylate and polypropylmethacrylate. In one preferred embodiment, the waveguide 44 is formed of quartz and fused to the end face of fiber 42.
  • [0095]
    Internal shaping of the waveguide can be accomplished by removing a portion of material from a unitary body, e.g., a cylinder or rod. Methods known in the art can be utilized to modify waveguide to have tapered inner walls, e.g., by grinding, milling, ablating, etc. In one approach, a hollow polymeric cylinder, e.g., a tube, is heated so that the proximal end collapses and fuses together, forming an integral proximal portion which tapers to the distal end of the waveguide. In another approach, the conical surface 45 can be formed in a solid quartz cylinder or rod by drilling with a tapered bore.
  • [0096]
    Waveguide 44 can be optical coupled to optical fiber 42 by various methods known in the art. These methods include for example, gluing, or fusing with a torch or carbon dioxide laser. In one embodiment (shown in FIG. 19), waveguide 44, optical fiber 42 and, optionally, a gradient index lens (GRIN) 46 are in communication and are held in position by heat shrinking a polymeric jacket material 68, such as polyethylene terephthalate (PET) about the optical apparatus 40.
  • [0097]
    FIG. 18 is a schematic illustration of another embodiment of a radiant energy emitter 40A according to the invention in which optical fiber 42 is coupled to a light diffuser 41 having light scattering particles 47 to produce a sidewise cylindrical exposure pattern of ablative radiation. This embodiment can be useful, for example, in creating a lesion within a pulmonary vein. With reference again to FIG. 1, it should be clear that the radiant energy emitter of the design shown in FIG. 14 can be advanced to front of the projection balloon to permit diffuse exposure of a pulmonary vein ostium if a lesion is desired in that location. For further details on the construction of light diffusing elements, see U.S. Pat. No. 5,908,415 issued to Sinofsky on Jun. 1, 1999, herein incorporated by reference.
  • [0098]
    FIG. 19 illustrates an alternative embodiment of a radiant energy emitter 40C in which an ultrasound transducer 60, comprising individual shaped transducer elements or lenses 62 which direct the ultrasound energy into a cone of energy that can likewise form an annular exposure pattern upon impingement with a target surface. The emitter 40C is supported by a sheath 66 or similar elongate body, enclosing electrical leads, and thereby permitting the clinician to advance the emitter through an inner lumen of the instrument to a desired position for ultrasound emission.
  • [0099]
    Yet another embodiment of a radiant energy emitter 40D is illustrated in FIG. 20 where microwave energy is similarly focused into an annular exposure beam. As shown in FIG. 20, the radiant energy emitter can include a coaxial transmission line 74 (or similar electrical signal leads) and a helical coil antenna 73. Radiation reflectors 72A and 72B cooperated to shield and direct the radiation into a cone. In other embodiments, a radioisotope or other source of ionizing radiation can be used in lieu of the microwave antenna 73, again with appropriate radiation shielding elements 72A and 72B to project a beam of ionizing radiation.
  • [0100]
    FIGS. 21 and 22 illustrate one embodiment of a contact sensor according to the invention incorporated into a radiant emitter assembly. The assembly can includes an outer, radiant energy transparent body 70 that encases the assembly and facilitates its slidable positioning within an inner lumen of catheter body 14. The assembly further includes an energy emitter 40 (e.g., like those described above in connection with FIGS. 17-20) which can also act as the sensing fiber. In the illustrated embodiment, four illumination fibers 76A-76D are shown. If the ablative apparatus of the invention is properly positioned within the heart, light transmitted via such fibers will strike the target region, be reflected back, and detected by the energy emitter (or other sensing element). The use of four illumination fibers allows simultaneous or sequential sensing of contact in four “quadrants.” (It should be clear that the invention can be practiced with various numbers of illuminating and/or sensing elements, and with or without use of the energy emitter as an element in the contact sensing module. Moreover, ultrasound emitters and detectors can also be used in the same manner in lieu of the light reflecting mechanisms to determine contact. In any event, the output signals of the sensors can be electronically processed and incorporated into a display.) The sensors of FIGS. 21-22 provide the ability to position the percutaneous ablation instruments of the present invention at a treatment site such that proper location of the energy emitter vis-a-vis the target tissue (as well a satisfactory degree of contact between the projection balloon and the tissue) is achieved. This ability is based on reflectance measurements of light scattered or absorbed by blood, body fluids and tissue. For example, white light projected from sensing fibers 76 toward tissue has several components including red and green light. Red light has a wavelength range of about 600 to about 700 nanometers (nm) and green light has a wavelength range of about 500 to about 600 nm. When the projected light encounters blood or body fluids, most if not all green light is absorbed and hence very little green or blue light will be reflected back toward the optical assembly which includes a reflected light collector. As the apparatus is positioned such that blood and body fluids are removed from the treatment field cleared by an inflated balloon member, the reflectance of green and blue light increases as biological tissue tends to reflect more green light. As a consequence, the amount of reflected green or blue light determines whether there is blood between the apparatus and the tissue or not.
  • [0101]
    For example, as the instrument is positioned in a heart chamber, the green-blue reflectance signal should remain nearly at zero until the projection balloon is inflated and positioned proximal to the surface of the heart tissue. When the inflated balloon member contacts the heart tissue (or is close enough that the balloon and ablative fluid released by the instrument form a clear transmission pathway), green light is reflected back into the optical assembly and the collector. In one embodiment, only green light is projected toward the tissue surface. In another embodiment, red and green light are both projected toward the tissue surface. The red and green light can be transmitted simultaneously or separately. The use of both red and green light provides the advantage that there is no requirement that the operator needs to know how much light must be transmitted into the balloon toward the tissue surface to insure that a reflectance signal is returned. The ratio of the two different wavelengths can be measured. For example, the instrument can measure reflectance of both green light and red light. When the intensity of the light is sufficient, reflected red light is detected throughout the positioning process. Prior to contact of the instrument, and more specifically the inflated balloon, with the tissue the ratio of red light to green light would be high. Once a transmission pathway is established, the ratio drops since more light is reflected from the tissue without any intervening blood to absorb the green light.
  • [0102]
    The reflected light is transmitted back through a collector, such as an optical fiber to a spectrophotometer. The spectrophotometer (Ocean Optics Spectrometer, Dunedin, Fla., model S-2000) produces a spectrum for each reflected pulse of reflected light. Commercially available software (LabView Software, Austin, Tex.) can isolate values for specific colors and perform ratio analyses.
  • [0103]
    In any event, the use of multiple optical fiber illumination fibers positioned about the lumen of the catheter, permit the operator to determine the plane in which the catheter and balloon should be adjusted to minimize blood between the optical assembly and the treatment site.
  • [0104]
    One suitable optical fiber/collector is described in U.S. Pat. No. 6,071,302, issued to Edward Sinofsky on Jun. 6, 2000, the contents of which are incorporated herein by reference.
  • [0105]
    Once the operator is satisfied with the positioning of the instrument, radiant energy can then be projected to the target tissue region. If the radiant energy is electromagnetic radiation, e.g., laser radiation, it can be emitted onto the tissue site via a separate optical fiber or, alternatively, through the same optical fiber used to transmitting the white, green or red light. The laser light can be pulsed intermittently in synchronous fashion with the positioning/reflecting light to ensure that the pathway remains clear throughout the procedure.
  • [0106]
    It should be clear that the contact sensing aspects of the present invention are not limited to radiant energy ablation devices but can also be useful in placement of contact heating or cooling ablation instruments as well. For example, in FIG. 23, a contact-heating device 54 having an expandable element 56 and a contact heating element 58 is shown disposed in a pulmonary vein. The contact heating element can be a line or grid of electrically conductive material printed on the surface of the expandable element. In one embodiment, the expandable element can be substantially opaque to certain wavelengths (e.g., visible light) except for a transparent band 59, on which the contact heating element is situated. The heating wires should also be sufficiently transparent (or cover a substantially small area of the band) so as to not interfere with reflection signal collection. The device 54 can further include a sensor disposed within a central lumen of the device having an illuminating fiber and and a plurality of collecting fibers
  • [0107]
    The contact sensor can operate in substantially same fashion as described above. For example, when the ablation device 54 of FIG. 23 is positioned in a pulmonary vein, and illuminated with light from within, a green-blue reflectance signal should remain nearly at zero until the expandable element 56 is inflated and positioned proximal to the surface of the heart tissue. When the portion of inflated expandable element 56 that carries the ablation band 58 contacts the heart tissue, green light is reflected back into the optical assembly and the collector. In one embodiment, only green light is projected toward the tissue surface. In another embodiment, red and green light are both projected toward the tissue surface. The red and green light can be transmitted simultaneously or separately. Again, the use of both red and green light provides the advantage that there is no requirement that the operator needs to know how much light must be transmitted into the balloon toward the tissue surface to insure that a reflectance signal is returned. The ratio of the two different wavelengths can be measured. For example, the instrument can measure reflectance of both green light and red light. When the intensity of the light is sufficient, reflected red light is detected throughout the positioning process. Prior to contact of the instrument, and more specifically the contact-heating ablation band, with the tissue, the ratio of red light to green light would be high. Once contact is established, the ratio drops since more light is reflected from the tissue without any intervening blood to absorb the green light.
  • [0108]
    In FIG. 23A, another embodiment of a contact sensing catheter is shown in the form of a cryogenic ablation catheter 110 having a catheter body 112 and internal conduits 114 for circulation of a cryogenic fluid from a cryogenic fluid source 115. The catheter body includes conductive regions 116 where the cold temperature can be applied to tissue. The sensors 76 of the present invention can be disposed in proximity to the conductive regions, as shown and used to determine whether tissue contact has been made.
  • [0109]
    In FIG. 23B yet another application for the contact sensors is shown in connection with an ultrasound, contact-heating balloon catheter 120, having a balloon 122 (similar to that discussed above in connection with FIG. 23) for contacting a pulmonary vein and having a band 123 for applying heat to tissue. The ultrasound ablation instrument 120 further includes transducers 124 driven by actuator 125 to heat the ablative band 123. Again, the sensors 76 of the present invention can be disposed in proximity to the ablation band 123, as shown, and used to determine whether tissue contact has been made.
  • [0110]
    In FIG. 24, a translatory mechanism 80 is shown for controlled movement of a radiant energy emitter within the instruments of the present invention. The exemplary positioner 80 is incorporated into a handle 84 in the proximal region of the instrument, where the elongate body 82 of the radiant energy emitter 40 engages a thumb wheel 86 to control advancement and retraction of the emitter. It should be clear that various alternative mechanisms of manual or automated nature can be substituted for the illustrated thumb wheel 86 to position the emitter at a desired location relative to the target tissue region.
  • [0111]
    In addition, as shown in FIG. 24, the elongate body 82 that supports the radiant energy emitter 40 (e.g., an optical fiber assembly as shown in FIGS. 21-22 or the sheath for the electrical leads as shown in connection with FIGS. 19-20) can further include position indicia 92 on its surface to assist the clinician in placement of the emitter within the projection balloon. The handle can further include a window 90 whereby the user can read the indicia (e.g., gradation markers) to gauge how far the emitter has been advanced into the instrument.
  • [0112]
    Although described in connection with cardiac ablation procedures, it should be clear that the instruments of the present invention can be used for a variety of other procedures where treatment with radiant energy is desirable, including laparoscopic, endoluminal, perivisceral, endoscopic, thoracoscopic, intra-articular and hybrid approaches.
  • [0113]
    The term “radiant energy” as used herein is intended to encompass energy sources that do not rely primarily on conductive or convective heat transfer. Such sources include, but are not limited to, acoustic and electromagnetic radiation sources and, more specifically, include microwave, x-ray, gamma-ray, and radiant light sources. The term “light” as used herein is intended to encompass electromagnetic radiation including, but not limited to, visible light, infrared and ultraviolet radiation.
  • [0114]
    The term “continuous” in the context of a lesion is intended to mean a lesion that substantial blocks electrical conduction between tissue segments on opposite sides of the lesion. The terms “circumferential” and/or “curvilinear,” including derivatives thereof, are herein intended to mean a path or line which forms an outer border or perimeter that either partially or completely surrounds a region of tissue, or separate one region of tissue from another. Further, a “circumferential” path or element may include one or more of several shapes, and may be for example, circular, annular, oblong, ovular, elliptical, or toroidal.
  • [0115]
    The term “lumen,” including derivatives thereof, in the context of biological structures, is herein intended to mean any cavity or lumen within the body which is defined at least in part by a tissue wall. For example, cardiac chambers, the uterus, the regions of the gastrointestinal tract, the urinary tract, and the arterial or venous vessels are all considered illustrative examples of body spaces within the intended meaning.
  • [0116]
    The term “catheter” as used herein is intended to encompass any hollow instrument capable of penetrating body tissue or interstitial cavities and providing a conduit for selectively injecting a solution or gas, including without limitation, venous and arterial conduits of various sizes and shapes, bronchoscopes, endoscopes, cystoscopes, culpascopes, colonscopes, trocars, laparoscopes and the like. Catheters of the present invention can be constructed with biocompatible materials known to those skilled in the art such as those listed supra, e.g., silastic, polyethylene, Teflon, polyurethanes, etc. The term “lumen,” including derivatives thereof, in the context of catheters is intended to encompass any passageway within a catheter instrument (and/or track otherwise joined to such instrument that can serve as a passageway) for the passage of other component instruments or fluids or for delivery of therapeutic agents or for sampling or otherwise detecting a condition at a remote region of the instrument.
  • [0117]
    It should be understood that the term “balloon” encompasses deformable hollow shapes which can be inflated into various configurations including balloon, circular, tear drop, etc., shapes dependent upon the requirements of the body cavity. Such balloon elements can be elastic or simply capable of unfolding or unwrapping into an expanded state.
  • [0118]
    The term “transparent” is well recognized in the art and is intended to include those materials which allow transmission of energy through, for example, the primary balloon member. Preferred transparent materials do not significantly impede (e.g., result in losses of over 20 percent of energy transmitted) the energy being transferred from an energy emitter to the tissue or cell site. Suitable transparent materials include fluoropolymers, for example, fluorinated ethylene propylene (FEP), perfluoroalkoxy resin (PFA), polytetrafluoroethylene (PTFE), and ethylene-tetrafluoroethylene (ETFE).
  • [0119]
    One skilled in the art will appreciate further features and advantages of the invention based on the above-described embodiments. Accordingly, the invention is not to be limited by what has been particularly shown and described, except as indicated by the appended claims. All publications and references cited herein are expressly incorporated herein by reference in their entirety.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US224929 *May 14, 1879Feb 24, 1880 Land-marker
US961738 *Feb 12, 1910Jun 14, 1910John H StickelCombined check and gate valve.
US3821510 *Feb 22, 1973Jun 28, 1974Muncheryan HHand held laser instrumentation device
US4336809 *Mar 17, 1980Jun 29, 1982Burleigh Instruments, Inc.Human and animal tissue photoradiation system and method
US4585298 *Aug 8, 1983Apr 29, 1986Kei MoriPhotoradiator for radiating light
US4660925 *Apr 29, 1985Apr 28, 1987Laser Therapeutics, Inc.Apparatus for producing a cylindrical pattern of light and method of manufacture
US4701166 *Oct 2, 1986Oct 20, 1987Catheter Technology Corp.Valved two-way catheter
US4718417 *Mar 22, 1985Jan 12, 1988Massachusetts Institute Of TechnologyVisible fluorescence spectral diagnostic for laser angiosurgery
US4819632 *May 19, 1987Apr 11, 1989Davies David HRetrolasing catheter and method
US4852567 *Jan 21, 1988Aug 1, 1989C. R. Bard, Inc.Laser tipped catheter
US4860743 *Jun 3, 1987Aug 29, 1989University Of FloridaLaser method and apparatus for the recanalization of vessels and the treatment of other cardiac conditions
US4862886 *May 8, 1985Sep 5, 1989Summit Technology Inc.Laser angioplasty
US4913142 *May 26, 1987Apr 3, 1990Massachusetts Institute Of TechnologyCatheter for laser angiosurgery
US5026367 *Mar 18, 1988Jun 25, 1991Cardiovascular Laser Systems, Inc.Laser angioplasty catheter and a method for use thereof
US5053033 *Oct 10, 1990Oct 1, 1991Boston Advanced Technologies, Inc.Inhibition of restenosis by ultraviolet radiation
US5078681 *Oct 23, 1989Jan 7, 1992Olympus Optical Co., Ltd.Balloon catheter apparatus with releasable distal seal and method of operation
US5090959 *Sep 13, 1990Feb 25, 1992Advanced Cardiovascular Systems, Inc.Imaging balloon dilatation catheter
US5109859 *Oct 4, 1989May 5, 1992Beth Israel Hospital AssociationUltrasound guided laser angioplasty
US5125925 *Dec 11, 1990Jun 30, 1992Photoradiation SystemsIntracavity laser catheter with sensing fiber
US5133709 *Feb 23, 1990Jul 28, 1992Prince Martin ROptical fiber with atraumatic rounded end for use in laser angioplasty
US5140987 *Jan 19, 1991Aug 25, 1992Wayne State UniversityMethod for transvenous ablation of cardiac electrically conductive tissue by laser photocoagulation
US5151096 *Mar 28, 1991Sep 29, 1992Angiolaz, IncorporatedLaser catheter diffuser
US5151097 *Aug 28, 1990Sep 29, 1992S.L.T. Japan Co., Ltd.Laser light emitter
US5188632 *Oct 3, 1990Feb 23, 1993Advanced Interventional Systems, Inc.Guidance and delivery system for high-energy pulsed laser light
US5188634 *Jul 13, 1990Feb 23, 1993Trimedyne, Inc.Rotatable laser probe with beveled tip
US5190538 *Apr 22, 1991Mar 2, 1993Trimedyne, Inc.Method and apparatus for subjecting a body site to a movable beam of laterally directed laser radiation
US5196005 *Nov 26, 1991Mar 23, 1993Pdt Systems, Inc.Continuous gradient cylindrical diffusion tip for optical fibers and method for making
US5207699 *Nov 8, 1991May 4, 1993Coe Frederick LLancet handling and disposal assembly
US5209748 *Jun 16, 1992May 11, 1993S.L.T. Japan Co., Ltd.Laser light irradiation apparatus
US5219346 *Jan 4, 1991Jun 15, 1993Ciba-Geigy CorporationLight diffuser for the photodynamic therapy of tumors in the oesophagus of a patient
US5242438 *Apr 22, 1991Sep 7, 1993Trimedyne, Inc.Method and apparatus for treating a body site with laterally directed laser radiation
US5330465 *Oct 30, 1992Jul 19, 1994Laser Therapeutics, Inc.Continuous gradient cylindrical diffusion tip for optical fibers and method for using
US5337381 *Jan 21, 1993Aug 9, 1994Fiberguide IndustriesFiber optic cylindrical diffuser
US5350375 *Mar 15, 1993Sep 27, 1994Yale UniversityMethods for laser induced fluorescence intensity feedback control during laser angioplasty
US5380316 *Jun 16, 1993Jan 10, 1995Advanced Cardiovascular Systems, Inc.Method for intra-operative myocardial device revascularization
US5395362 *Jan 14, 1992Mar 7, 1995Summit TechnologyMethods and apparatus for distributing laser radiation
US5401270 *Jan 24, 1994Mar 28, 1995Carl-Zeiss-StiftungApplicator device for laser radiation
US5409483 *May 14, 1993Apr 25, 1995Jeffrey H. ReeseDirect visualization surgical probe
US5417653 *Jan 21, 1993May 23, 1995Sahota; HarvinderMethod for minimizing restenosis
US5423805 *Mar 15, 1993Jun 13, 1995Angeion CorporationLaser catheter with moveable integral fixation wires
US5427119 *Nov 3, 1993Jun 27, 1995Daig CorporationGuiding introducer for right atrium
US5431647 *Jul 13, 1994Jul 11, 1995Pioneer Optics CompanyFiberoptic cylindrical diffuser
US5437660 *Dec 30, 1991Aug 1, 1995Trimedyne, Inc.Tissue ablation and a lateral-lasing fiber optic device therefor
US5441497 *Jul 14, 1994Aug 15, 1995Pdt Cardiovascular, Inc.Light diffusing guidewire
US5482037 *Jan 13, 1994Jan 9, 1996X-Trode S.R.L.Electrode catheter for mapping and operating on cardiac cavities
US5496305 *Jan 29, 1992Mar 5, 1996Massachusetts Institue Of TechnologyCatheter for laser angiosurgery
US5497774 *Nov 3, 1993Mar 12, 1996Daig CorporationGuiding introducer for left atrium
US5507725 *Dec 22, 1993Apr 16, 1996Angeion CorporationSteerable catheter
US5531664 *Jul 25, 1994Jul 2, 1996Olympus Optical Co., Ltd.Bending actuator having a coil sheath with a fixed distal end and a free proximal end
US5536265 *Mar 17, 1995Jul 16, 1996Ciba-Geigy CorporationLight diffuser and process for the manufacturing of a light diffuser
US5613965 *Dec 8, 1994Mar 25, 1997Summit Technology Inc.Corneal reprofiling using an annular beam of ablative radiation
US5643253 *Jun 6, 1995Jul 1, 1997Rare Earth Medical, Inc.Phototherapy apparatus with integral stopper device
US5649923 *Apr 8, 1994Jul 22, 1997The General Hospital CorporationCatheter devices for delivering laser energy
US5680860 *Oct 31, 1995Oct 28, 1997Cardiac Pathways CorporationMapping and/or ablation catheter with coilable distal extremity and method for using same
US5722401 *Nov 13, 1995Mar 3, 1998Cardiac Pathways CorporationEndocardial mapping and/or ablation catheter probe
US5725522 *Jun 7, 1995Mar 10, 1998Rare Earth Medical, Inc.Laser suturing of biological materials
US5759619 *Dec 24, 1996Jun 2, 1998Lg Electronics Inc.Method of manufacturing second harmonic generation device
US5769843 *Feb 20, 1996Jun 23, 1998CormedicaPercutaneous endomyocardial revascularization
US5772590 *Jun 7, 1995Jun 30, 1998Cordis Webster, Inc.Cardiovascular catheter with laterally stable basket-shaped electrode array with puller wire
US5779646 *Aug 27, 1997Jul 14, 1998E.P. Technologies Inc.Deflectable biopsy catheter
US5782239 *Jun 7, 1995Jul 21, 1998Cordis Webster, Inc.Unique electrode configurations for cardiovascular electrode catheter with built-in deflection method and central puller wire
US5782899 *Aug 28, 1996Jul 21, 1998Cardiac Pathways CorporationEndocardial mapping and ablation system utilizing a separately controlled ablation catheter and method
US5800482 *Mar 6, 1996Sep 1, 1998Cardiac Pathways CorporationApparatus and method for linear lesion ablation
US5807395 *Apr 22, 1997Sep 15, 1998Medtronic, Inc.Method and apparatus for RF ablation and hyperthermia
US5823955 *Nov 20, 1995Oct 20, 1998Medtronic CardiorhythmAtrioventricular valve tissue ablation catheter and method
US5824005 *Aug 22, 1995Oct 20, 1998Board Of Regents, The University Of Texas SystemManeuverable electrophysiology catheter for percutaneous or intraoperative ablation of cardiac arrhythmias
US5860974 *Feb 11, 1997Jan 19, 1999Boston Scientific CorporationHeart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft
US5885278 *Oct 11, 1994Mar 23, 1999E.P. Technologies, Inc.Structures for deploying movable electrode elements
US5891133 *Mar 29, 1996Apr 6, 1999Eclipse Surgical Technologies, Inc.Apparatus for laser-assisted intra-coronary transmyocardial revascularization and other applications
US5891134 *Sep 24, 1996Apr 6, 1999Goble; ColinSystem and method for applying thermal energy to tissue
US5904651 *Oct 28, 1996May 18, 1999Ep Technologies, Inc.Systems and methods for visualizing tissue during diagnostic or therapeutic procedures
US5908415 *Apr 10, 1997Jun 1, 1999Rare Earth Medical, Inc.Phototherapy methods and apparatus
US5931834 *Jul 31, 1997Aug 3, 1999Eclipse Surgical Technologies, Inc.Method for non-synchronous laser-assisted myocardial revascularization
US5938660 *Jun 27, 1997Aug 17, 1999Daig CorporationProcess and device for the treatment of atrial arrhythmia
US6012457 *Jul 8, 1997Jan 11, 2000The Regents Of The University Of CaliforniaDevice and method for forming a circumferential conduction block in a pulmonary vein
US6024740 *Jul 8, 1997Feb 15, 2000The Regents Of The University Of CaliforniaCircumferential ablation device assembly
US6064902 *Apr 16, 1998May 16, 2000C.R. Bard, Inc.Pulmonary vein ablation catheter
US6071279 *Dec 19, 1996Jun 6, 2000Ep Technologies, Inc.Branched structures for supporting multiple electrode elements
US6071281 *May 5, 1998Jun 6, 2000Ep Technologies, Inc.Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and remote power control unit for use with same
US6071302 *Dec 31, 1997Jun 6, 2000Cardiofocus, Inc.Phototherapeutic apparatus for wide-angle diffusion
US6086581 *Jul 30, 1993Jul 11, 2000Ep Technologies, Inc.Large surface cardiac ablation catheter that assumes a low profile during introduction into the heart
US6090084 *Feb 4, 1998Jul 18, 2000Daig CorporationShaped guiding introducers for use with a catheter for the treatment of atrial arrhythmia
US6117101 *Nov 25, 1998Sep 12, 2000The Regents Of The University Of CaliforniaCircumferential ablation device assembly
US6120496 *May 5, 1998Sep 19, 2000Scimed Life Systems, Inc.Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and coupling device for use with same
US6179835 *Apr 27, 1999Jan 30, 2001Ep Technologies, Inc.Expandable-collapsible electrode structures made of electrically conductive material
US6214002 *Mar 13, 2000Apr 10, 2001Ep Technologies, Inc.Structures and methods for deploying electrode elements
US6237605 *Sep 21, 1998May 29, 2001Epicor, Inc.Methods of epicardial ablation
US6245064 *Jan 11, 2000Jun 12, 2001Atrionix, Inc.Circumferential ablation device assembly
US6251109 *Jan 20, 1999Jun 26, 2001Daig CorporationProcess and device for the treatment of atrial arrhythmia
US6254599 *Mar 22, 1999Jul 3, 2001Atrionix, Inc.Circumferential ablation device assembly
US6383151 *Sep 11, 2000May 7, 2002Chris J. DiederichCircumferential ablation device assembly
US6416511 *Aug 17, 2000Jul 9, 2002The Regents Of The University Of CaliforniaCircumferential ablation device assembly
US6423055 *Jul 14, 1999Jul 23, 2002Cardiofocus, Inc.Phototherapeutic wave guide apparatus
US6502576 *Aug 17, 2000Jan 7, 2003The Regents Of The University Of CaliforniaDevice and method for forming a circumferential conduction block in a pulmonary vein
US6514249 *Mar 2, 2000Feb 4, 2003Atrionix, Inc.Positioning system and method for orienting an ablation element within a pulmonary vein ostium
US20020065512 *Jul 13, 2001May 30, 2002Todd FjieldThermal treatment methods and apparatus with focused energy application
US20020107511 *Apr 27, 2001Aug 8, 2002Collins Russell F.Apparatus and methods for mapping and ablation in electrophysiology procedures
US20090221996 *May 12, 2009Sep 3, 2009The Regents Of The University Of CaliforniaCircumferential ablation device assembly
USRE34544 *Nov 12, 1992Feb 15, 1994The Beth Israel Hospital AssociationMethod of treatment of artherosclerosis and balloon catheter the same
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7537570 *Sep 11, 2007May 26, 2009Stereotaxis, Inc.Automated mapping of anatomical features of heart chambers
US7645142Sep 5, 2007Jan 12, 2010Vivant Medical, Inc.Electrical receptacle assembly
US7674256Mar 9, 2010Boston Scientific Scimed, Inc.Treating internal body tissue
US7730894Jul 5, 2007Jun 8, 2010Light Sciences Oncology, Inc.Photodynamic therapy apparatus and method for vascular tissue treatment
US7860555Oct 25, 2005Dec 28, 2010Voyage Medical, Inc.Tissue visualization and manipulation system
US7860556Nov 16, 2006Dec 28, 2010Voyage Medical, Inc.Tissue imaging and extraction systems
US7918787Mar 16, 2007Apr 5, 2011Voyage Medical, Inc.Tissue visualization and manipulation systems
US7930016Nov 16, 2006Apr 19, 2011Voyage Medical, Inc.Tissue closure system
US7935108May 3, 2011Cardiofocus, Inc.Deflectable sheath catheters
US8050746Nov 1, 2011Voyage Medical, Inc.Tissue visualization device and method variations
US8078266Dec 13, 2011Voyage Medical, Inc.Flow reduction hood systems
US8123741Apr 23, 2009Feb 28, 2012Boston Scientific Scimed, Inc.Treating internal body tissue
US8131350Dec 20, 2007Mar 6, 2012Voyage Medical, Inc.Stabilization of visualization catheters
US8137333Jul 25, 2007Mar 20, 2012Voyage Medical, Inc.Delivery of biological compounds to ischemic and/or infarcted tissue
US8152795Apr 14, 2008Apr 10, 2012Cardiofocus, Inc.Method and device for cardiac tissue ablation
US8152800Jul 30, 2007Apr 10, 2012Vivant Medical, Inc.Electrosurgical systems and printed circuit boards for use therewith
US8217523 *Jan 14, 2009Jul 10, 2012Veryst Engineering LlcApparatus for in vivo energy harvesting
US8221310Aug 30, 2007Jul 17, 2012Voyage Medical, Inc.Tissue visualization device and method variations
US8231613May 2, 2011Jul 31, 2012Cardiofocus, Inc.Deflectable sheath catheters
US8235985Aug 7, 2012Voyage Medical, Inc.Visualization and ablation system variations
US8241272Jul 5, 2006Aug 14, 2012Cardiofocus, Inc.Methods for ablation with radiant energy
US8267932May 2, 2011Sep 18, 2012Cardiofocus, Inc.Deflectable sheath catheters
US8277444Aug 15, 2006Oct 2, 2012Cardiofocus, Inc.Treatment of atrial fibrillation by overlapping curvilinear lesions
US8280489 *Oct 2, 2012Nellcor Puritan Bennett LlcMethod and system for determining placement of a tracheal tube in a subject
US8298223Oct 30, 2012Covidien AgMethod and system for programming and controlling an electrosurgical generator system
US8323275 *Dec 4, 2012Vivant Medical, Inc.Laparoscopic port with microwave rectifier
US8333012Dec 18, 2012Voyage Medical, Inc.Method of forming electrode placement and connection systems
US8343145Sep 28, 2009Jan 1, 2013Vivant Medical, Inc.Microwave surface ablation using conical probe
US8366705Apr 16, 2009Feb 5, 2013Cardiofocus, Inc.Coaxial catheter instruments for ablation with radiant energy
US8366706Feb 5, 2013Cardiodex, Ltd.Systems and methods for puncture closure
US8372072Feb 12, 2013Cardiodex Ltd.Methods and apparatus for hemostasis following arterial catheterization
US8417321Apr 9, 2013Voyage Medical, IncFlow reduction hood systems
US8419613Apr 16, 2013Voyage Medical, Inc.Tissue visualization device
US8435236Nov 21, 2005May 7, 2013Cardiodex, Ltd.Techniques for heat-treating varicose veins
US8444639Jan 18, 2012May 21, 2013Cardiofocus, Inc.Coaxial catheter instruments for ablation with radiant energy
US8457715 *Jun 4, 2013Covidien LpSystem and method for determining placement of a tracheal tube
US8457716 *Jun 4, 2013Covidien LpTime of flight based tracheal tube placement system and method
US8540704Jun 10, 2004Sep 24, 2013Cardiofocus, Inc.Guided cardiac ablation catheters
US8552915 *Jun 19, 2009Oct 8, 2013Covidien LpMicrowave ablation antenna radiation detector
US8638428Jun 1, 2011Jan 28, 2014Joe Denton BrownMethod and apparatus for using optical feedback to detect fiber breakdown during surgical laser procedures
US8657805May 8, 2008Feb 25, 2014Intuitive Surgical Operations, Inc.Complex shape steerable tissue visualization and manipulation catheter
US8694071Feb 11, 2011Apr 8, 2014Intuitive Surgical Operations, Inc.Image stabilization techniques and methods
US8696653Oct 1, 2010Apr 15, 2014Cardiofocus, Inc.Cardiac ablation system with pulsed aiming light
US8702688Oct 6, 2010Apr 22, 2014Cardiofocus, Inc.Cardiac ablation image analysis system and process
US8709008May 9, 2008Apr 29, 2014Intuitive Surgical Operations, Inc.Visual electrode ablation systems
US8747398Sep 13, 2007Jun 10, 2014Covidien LpFrequency tuning in a microwave electrosurgical system
US8758229Dec 20, 2007Jun 24, 2014Intuitive Surgical Operations, Inc.Axial visualization systems
US8814845Feb 3, 2012Aug 26, 2014Intuitive Surgical Operations, Inc.Delivery of biological compounds to ischemic and/or infarcted tissue
US8834487 *Jul 23, 2010Sep 16, 2014Hologic, Inc.Systems and methods for preventing intravasation during intrauterine procedures
US8847830Oct 8, 2013Sep 30, 2014Covidien LpMicrowave ablation antenna radiation detector
US8858609Feb 6, 2009Oct 14, 2014Intuitive Surgical Operations, Inc.Stent delivery under direct visualization
US8886290Sep 10, 2012Nov 11, 2014Covidien LpMethod and system for determining placement of a tracheal tube in a subject
US8892182 *Feb 8, 2008Nov 18, 2014Ethicon, Inc.Double balloon isolation catheters and methods therefor
US8900219Apr 14, 2009Dec 2, 2014Cardiofocus, Inc.System and method for visualizing tissue during ablation procedures
US8934962Aug 31, 2007Jan 13, 2015Intuitive Surgical Operations, Inc.Electrophysiology mapping and visualization system
US8961551Dec 22, 2006Feb 24, 2015The Spectranetics CorporationRetractable separating systems and methods
US9028520Dec 22, 2006May 12, 2015The Spectranetics CorporationTissue separating systems and methods
US9033961Apr 14, 2009May 19, 2015Cardiofocus, Inc.Cardiac ablation catheters for forming overlapping lesions
US9055906May 12, 2010Jun 16, 2015Intuitive Surgical Operations, Inc.In-vivo visualization systems
US9101735Jul 7, 2009Aug 11, 2015Intuitive Surgical Operations, Inc.Catheter control systems
US9149334 *Oct 25, 2010Oct 6, 2015Dornier Medtech Laser GmbhLight-based method for the endovascular treatment of pathologically altered blood vessels
US9155452Apr 24, 2008Oct 13, 2015Intuitive Surgical Operations, Inc.Complex shape steerable tissue visualization and manipulation catheter
US9155587May 14, 2009Oct 13, 2015Intuitive Surgical Operations, Inc.Visual electrode ablation systems
US9168098 *Jun 10, 2013Oct 27, 2015Dornier Medtech Laser GmbhLight-based method for the endovascular treatment of pathologically altered blood vessels
US9190704Mar 19, 2012Nov 17, 2015Covidien LpElectrosurgical systems and printed circuit boards for use therewith
US9192287Jun 18, 2012Nov 24, 2015Intuitive Surgical Operations, Inc.Tissue visualization device and method variations
US9226648Dec 20, 2007Jan 5, 2016Intuitive Surgical Operations, Inc.Off-axis visualization systems
US9259270Nov 6, 2009Feb 16, 2016Joe Denton BrownApparatus and method for detecting overheating during laser surgery
US9283040Mar 13, 2013Mar 15, 2016The Spectranetics CorporationDevice and method of ablative cutting with helical tip
US9289226Jan 5, 2015Mar 22, 2016The Spectranetics CorporationRetractable separating systems and methods
US9291663Mar 13, 2013Mar 22, 2016The Spectranetics CorporationAlarm for lead insulation abnormality
US9314303Mar 23, 2011Apr 19, 2016Joe Denton BrownLaser surgery controller with variable time delay and feedback detector sensitivity control
US9332893Aug 5, 2014May 10, 2016Intuitive Surgical Operations, Inc.Delivery of biological compounds to ischemic and/or infarcted tissue
US9345543Jul 2, 2009May 24, 2016Joe Denton BrownLaser delivery apparatus for endovascular applications
US20050065504 *Jun 10, 2004Mar 24, 2005Gerald MelskyGuided cardiac ablation catheters
US20050222557 *Feb 22, 2005Oct 6, 2005Cardiofocus, Inc.Deflectable sheath catheters
US20060212027 *Mar 17, 2005Sep 21, 2006Nassir MarroucheTreating internal body tissue
US20060253113 *Jul 5, 2006Nov 9, 2006Cardiofocus, Inc.Methods for ablation with radiant energy
US20070049911 *Aug 28, 2006Mar 1, 2007Brown Joe DEndovascular method and apparatus with feedback
US20070055223 *Feb 3, 2004Mar 8, 2007Cardiodex, Ltd.Methods and apparatus for hemostasis following arterial catheterization
US20070167828 *Nov 16, 2006Jul 19, 2007Vahid SaadatTissue imaging system variations
US20070293724 *Jun 14, 2007Dec 20, 2007Voyage Medical, Inc.Visualization apparatus for transseptal access
US20080015445 *Jul 10, 2007Jan 17, 2008Voyage Medical, Inc.Tissue visualization device and method variations
US20080015569 *Jul 10, 2007Jan 17, 2008Voyage Medical, Inc.Methods and apparatus for treatment of atrial fibrillation
US20080027517 *Jul 5, 2007Jan 31, 2008Light Sciences Oncology, Inc.Light generating device for intravascular use
US20080033241 *Jul 25, 2007Feb 7, 2008Ruey-Feng PehLeft atrial appendage closure
US20080033519 *Aug 6, 2007Feb 7, 2008Light Sciences Oncology, Inc.Light generating device for intravascular use
US20080058591 *Aug 30, 2007Mar 6, 2008Voyage Medical, Inc.Tissue visualization device and method variations
US20080064969 *Sep 11, 2007Mar 13, 2008Nathan KasteleinAutomated Mapping of Anatomical Features of Heart Chambers
US20080154293 *Dec 22, 2006Jun 26, 2008The Spectranetics CorporationRetractable Separating Systems and Methods
US20080154296 *Dec 22, 2006Jun 26, 2008The Spectranetics CorporationTissue Separating Systems and Methods
US20080167643 *Nov 21, 2005Jul 10, 2008Cardiodex Ltd.Techniques for Heating-Treating Varicose Veins
US20080183036 *Dec 18, 2007Jul 31, 2008Voyage Medical, Inc.Systems and methods for unobstructed visualization and ablation
US20080195088 *Apr 14, 2008Aug 14, 2008Cardiofocus, Inc.Method and device for cardiac tissue ablation
US20080269846 *Apr 10, 2008Oct 30, 2008Light Sciences Oncology, Inc.Device for treatment of blood vessels using light
US20080275300 *Apr 24, 2008Nov 6, 2008Voyage Medical, Inc.Complex shape steerable tissue visualization and manipulation catheter
US20090030276 *Jul 25, 2008Jan 29, 2009Voyage Medical, Inc.Tissue visualization catheter with imaging systems integration
US20090030412 *May 9, 2008Jan 29, 2009Willis N ParkerVisual electrode ablation systems
US20090054803 *Aug 31, 2007Feb 26, 2009Vahid SaadatElectrophysiology mapping and visualization system
US20090061681 *Sep 5, 2007Mar 5, 2009Mcmunigal TomElectrical receptacle assembly
US20090062790 *Aug 29, 2008Mar 5, 2009Voyage Medical, Inc.Direct visualization bipolar ablation systems
US20090076498 *Sep 11, 2008Mar 19, 2009Voyage Medical, Inc.Visualization and ablation system variations
US20090125022 *Nov 10, 2008May 14, 2009Voyage Medical, Inc.Tissue visualization and ablation systems
US20090125056 *Aug 15, 2008May 14, 2009Cardiodex Ltd.Systems and methods for puncture closure
US20090143640 *Nov 25, 2008Jun 4, 2009Voyage Medical, Inc.Combination imaging and treatment assemblies
US20090152990 *Jan 14, 2009Jun 18, 2009Veryst Engineering LlcApparatus for in vivo energy harvesting
US20090177191 *Dec 11, 2008Jul 9, 2009Brown Joe DLaser surgery methods and apparatus
US20090203962 *Feb 6, 2009Aug 13, 2009Voyage Medical, Inc.Stent delivery under direct visualization
US20090203995 *Feb 8, 2008Aug 13, 2009Ethicon, Inc.Double balloon isolation catheters and methods therefor
US20090209951 *Apr 23, 2009Aug 20, 2009Boston Scientific Scimed, Inc.Treating Internal Body Tissue
US20090221871 *May 12, 2009Sep 3, 2009Voyage Medical, Inc.Precision control systems for tissue visualization and manipulation assemblies
US20090221997 *Apr 16, 2009Sep 3, 2009Cardiofocus, Inc.Coaxial catheter instruments for ablation with radiant energy
US20090275842 *Nov 5, 2009Vahid SaadatStabilization of visualization catheters
US20090299354 *Apr 14, 2009Dec 3, 2009Cardiofocus, Inc.Cardiac ablation catheters for forming overlapping lesions
US20090299363 *Dec 20, 2007Dec 3, 2009Vahid SaadatOff-axis visualization systems
US20090326320 *Apr 14, 2009Dec 31, 2009Cardiofocus, Inc.System and method for visualizing tissue during ablation procedures
US20090326572 *Jun 11, 2009Dec 31, 2009Ruey-Feng PehApparatus and methods for rapid tissue crossing
US20100004633 *Jan 7, 2010Voyage Medical, Inc.Catheter control systems
US20100004646 *Jul 2, 2009Jan 7, 2010Joe Denton BrownLaser delivery apparatus for endovascular applications
US20100010311 *Jan 14, 2010Voyage Medical, Inc.Methods and apparatus for efficient purging
US20100130836 *Nov 13, 2009May 27, 2010Voyage Medical, Inc.Image processing systems
US20100256629 *Apr 6, 2010Oct 7, 2010Voyage Medical, Inc.Methods and devices for treatment of the ostium
US20100261995 *Oct 14, 2010Nellcor Puritan Bennett LlcMedical device and technique for using the same
US20100261996 *Apr 8, 2009Oct 14, 2010Nellcor Puritan Bennett LlcMedical device and technique for using same
US20100274330 *Oct 28, 2010Light Sciences Oncology, Inc.Device for treatment of blood vessels using light
US20100280362 *May 4, 2009Nov 4, 2010Nellcor Puritan Bennett LlcTime of flight based tracheal tube placement system and method
US20100292558 *May 12, 2010Nov 18, 2010Voyage Medical, Inc.In-vivo visualization systems
US20100321192 *Jun 19, 2009Dec 23, 2010Vivant Medical, Inc.Microwave Ablation Antenna Radiation Detector
US20110015622 *Sep 28, 2010Jan 20, 2011Joe Denton BrownEndovascular method and apparatus with feedback
US20110054488 *Mar 3, 2011Gruber William HSystems and methods for preventing intravasation during intrauterine procedures
US20110060227 *Nov 16, 2010Mar 10, 2011Voyage Medical, Inc.Tissue visualization and manipulation system
US20110060298 *Nov 16, 2010Mar 10, 2011Voyage Medical, Inc.Tissue imaging and extraction systems
US20110077634 *Sep 28, 2009Mar 31, 2011Vivant Medical, Inc.Microwave Surface Ablation Using Conical Probe
US20110082449 *Oct 1, 2010Apr 7, 2011Cardiofocus, Inc.Cardiac ablation system with pulsed aiming light
US20110082450 *Oct 1, 2010Apr 7, 2011Cardiofocus, Inc.Cardiac ablation system with inflatable member having multiple inflation settings
US20110082451 *Apr 7, 2011Cardiofocus, Inc.Cardiac ablation image analysis system and process
US20110082452 *Oct 1, 2010Apr 7, 2011Cardiofocus, Inc.Cardiac ablation system with automatic safety shut-off feature
US20110125140 *Oct 25, 2010May 26, 2011Domier MedTech Laser GmbHLight-Based Method for the Endovascular Treatment of Pathologically Altered Blood Vessels
US20110213241 *Sep 1, 2011Vivant Medical, Inc.Laparoscopic Port with Microwave Rectifier
US20110213349 *Nov 6, 2009Sep 1, 2011Joe Denton BrownApparatus and method for detecting overheating during laser surgery
US20110238048 *Sep 29, 2011Joe Denton BrownLaser surgery controller with variable time delay and feedback detector sensitivity control
US20130289547 *Jun 10, 2013Oct 31, 2013Tobias BeckLight-Based Method for the Endovascular Treatment of Pathologically Altered Blood Vessels
WO2010018569A1 *Aug 10, 2009Feb 18, 2010Cardionova Ltd.Method and apparatus for intra-atrial ablation
Classifications
U.S. Classification606/15, 606/33, 606/27
International ClassificationA61F2/958, A61L2/10, A61N5/06, A61B17/00, A61L29/08, A61B18/00, A61N7/02, A61B18/24, A61B19/00, A61B18/22
Cooperative ClassificationA61L29/085, A61B2017/00057, A61L2/10, A61B2018/2261, A61B18/24, A61B2018/2266, A61B2018/2272, A61B2090/065, A61B2017/00061, A61B18/245, A61N7/02, A61B2018/0097
European ClassificationA61L29/08B, A61B18/24, A61B18/24B, A61L2/10
Legal Events
DateCodeEventDescription
Jul 23, 2003ASAssignment
Owner name: CARDIOFOCUS, INC., MASSACHUSETTS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ARNOLD, JEFFREY M.;SINOFSKY, EDWARD L.;BAXTER, LINCOLN S.;AND OTHERS;REEL/FRAME:014302/0237;SIGNING DATES FROM 20030609 TO 20030626
Owner name: CARDIOFOCUS, INC., MASSACHUSETTS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ARNOLD, JEFFREY M.;SINOFSKY, EDWARD L.;BAXTER, LINCOLN S.;AND OTHERS;SIGNING DATES FROM 20030609 TO 20030626;REEL/FRAME:014302/0237
May 11, 2005ASAssignment
Owner name: VENTURE LENDING & LEASING IV, INC., CALIFORNIA
Free format text: SECURITY INTEREST;ASSIGNOR:CARDIOFOCUS, INC.;REEL/FRAME:016547/0536
Effective date: 20050415
Jul 3, 2014ASAssignment
Owner name: CARDIOFOCUS, INC., MASSACHUSETTS
Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:VENTURE LENDING & LEASING IV, INC.;REEL/FRAME:033275/0601
Effective date: 20061109
Jul 31, 2014ASAssignment
Owner name: SILICON VALLEY BANK, MASSACHUSETTS
Free format text: SECURITY INTEREST;ASSIGNOR:CARDIOFOCUS, INC.;REEL/FRAME:033434/0399
Effective date: 20140730
Owner name: OXFORD FINANCE LLC, VIRGINIA
Free format text: SECURITY INTEREST;ASSIGNOR:CARDIOFOCUS, INC.;REEL/FRAME:033434/0399
Effective date: 20140730
Mar 20, 2015FPAYFee payment
Year of fee payment: 4
Apr 24, 2015ASAssignment
Owner name: OXFORD FINANCE LLC, VIRGINIA
Free format text: SECURITY AGREEMENT;ASSIGNOR:CARDIOFOCUS, INC.;REEL/FRAME:035497/0393
Effective date: 20150424
Owner name: SILICON VALLEY BANK, MASSACHUSETTS
Free format text: SECURITY AGREEMENT;ASSIGNOR:CARDIOFOCUS, INC.;REEL/FRAME:035497/0393
Effective date: 20150424